1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with dinoprostone in 272 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 75 (27.57) | 18.7374 |
| 1990's | 141 (51.84) | 18.2507 |
| 2000's | 46 (16.91) | 29.6817 |
| 2010's | 9 (3.31) | 24.3611 |
| 2020's | 1 (0.37) | 2.80 |
| Authors | Studies |
|---|---|
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Hellewell, PG; Jose, PJ; Williams, TJ | 2 |
| Braquet, P; Egido, J; Garcia-Hoyo, R; González, E; Herrero-Beaumont, G; Maestre, C; Navarro, FJ; Zarco, P | 1 |
| de Lima, WT; Jancar, S; Sirois, P | 1 |
| Chao, W; Hanahan, DJ; Liu, H; Olson, MS | 1 |
| Beusenberg, FD; Bonta, IL; Brouwers, JW; Hekking, PR; Hoogsteden, HC; Schermers, HP; Van Amsterdam, JG | 1 |
| Lianos, EA; Zanglis, A | 1 |
| de Vries, JE; de Waal Malefyt, R; Deryckx, S; Gauchat, JF; Thomas, Y; Vivier, E | 1 |
| Ikeuchi, H; Mason, AD; Pruitt, BA; Sakano, T; Sanchez, J | 1 |
| Elder, MG; Khan, H; Morris, C; Sullivan, MH | 1 |
| Cardillo, R; DiMuzio, J; Post, TJ; Raible, DG; Schulman, ES | 1 |
| Cunningham, FM; Foster, AP; Lees, P | 1 |
| Chaussade, S; Denizot, Y | 1 |
| Abiko, Y; Izumi, H; Moriya, Y; Ogura, N; Shibata, Y; Takiguchi, H | 1 |
| Beilin, LJ; Croft, KD; Moulton, C; Proudfoot, J | 1 |
| Alonso, J; Bustos, C; Egido, J; Goméz-Chiarri, M; Gómez-Guerrero, C; González, E; Lerma, JL; Ortiz, A; Robles, A | 1 |
| Anglin, CP; Clapp, NK; Fretland, DJ; Gaginella, TS; Hansard, RM; Henke, MA; Walsh, RE; Widomski, DL | 1 |
| Brain, SD; Buckley, TL; Collins, PD; Williams, TJ | 1 |
| Furman, BL; Gray, GA; Parratt, JR | 1 |
| Flower, RJ; Peers, SH | 1 |
| Karmeli, F; Lysy, J; Rachmilewitz, D; Wengrower, D | 1 |
| Catto-Smith, AG; Gall, DG; MacNaughton, WK | 1 |
| Gall, DG; MacNaughton, WK | 1 |
| Hirasawa, N; Mue, S; Ohuchi, K; Omata, M; Tsurufuji, S; Watanabe, M | 1 |
| Benedetto, C; Hammerstein, J; Leo-Rossberg, I; Lübbert, H; Nigam, S; Zonca, M | 1 |
| Asmis, R; Dennis, EA; Glaser, KB | 2 |
| Bry, K; Hallman, M | 1 |
| Hatakeyama, K; Watanabe, K; Yano, S | 1 |
| Agrawal, DK; Bergren, DR; Byorth, PJ; Townley, RG | 1 |
| Katayama, T | 1 |
| Bishai, I; Coceani, F; Hynes, N; Lees, J | 1 |
| Barden, A; Nies, AS; Sturm, M; Tunney, A; Vandongen, R | 1 |
| Kimura, I; Kimura, M; Kobayashi, S; Nakagawa, M | 1 |
| Imanishi, M; Miura, K; Okumura, M; Shimmen, T; Yamamoto, K; Yamanaka, S; Yamashita, Y; Yukimura, T | 1 |
| Alecozay, AA; Hanahan, DJ; Harper, MJ; Schenken, RS | 1 |
| Gimbrone, MA; Hrbolich, JK; Schafer, AI; Zavoico, GB | 1 |
| Bazan, NG; Quinn, JH | 1 |
| Chao, W; Hanahan, DJ; Liu, HL; Olson, MS; Zhou, WG | 1 |
| Inagaki, N; Koda, A; Miura, T; Nagai, H; Ohira, K; Xu, QA | 1 |
| DiSimone, AG; Earnest, MA; Fletcher, JR | 1 |
| Csato, M; Dobozy, A; Judák, R; Kenderessy, AS | 1 |
| Dunlop, ME; Larkins, RG | 1 |
| Barthelson, RA; Potter, T; Valone, FH | 1 |
| Badr, KF; Blair, I; Christman, BW; Schreiner, GF; Takahashi, K; Yamashita, K | 1 |
| Chapman, FA; Cramer, DV; Makowka, L; Qian, SG; Starzl, TE; Sun, H | 1 |
| Brain, SD; Williams, TJ | 1 |
| Baber, NS; Bolognese, JA; Goldenberg, MM; James, I; Sciberras, DG | 1 |
| Hecker, G; Ney, P; Schröder, H; Schrör, K | 1 |
| Barnes, PJ; Chung, KF; McCusker, MT; Roberts, NM | 1 |
| Fisher, GJ; Ryder, NS; Talwar, HS; Voorhees, JJ | 1 |
| DeCandido, S; Hassid, A; Satriano, JA; Schlondorff, D; Singhal, P | 1 |
| Dennis, EA; Glaser, KB; Lister, MD; Ulevitch, RJ | 1 |
| Northover, AM | 1 |
| Mitchell, MD; Weinreb, RN | 1 |
| Faustman, EM; Geissler, FT; Henderson, WR; Kuzan, FB | 1 |
| Armstrong, ML; Harrison, DG; Heistad, DD; Lopez, JA; Piegors, DJ | 1 |
| Emery, D; Margolskee, D; Nadel, JA; Ueki, IF; Widdicombe, JH; Yergey, J | 1 |
| Braquet, P; Jancar, S; Sirois, P | 3 |
| Adolfs, MJ; Bachelet, M; Bereziat, G; Bonta, IL; Masliah, J; Vargaftig, BB | 2 |
| Buckley, TL; Hoult, JR | 1 |
| Errasfa, M; Maridonneau-Parini, I; Russo-Marie, F | 1 |
| Fisher, RA; Hanahan, DJ; Olson, MS; Revtyak, GE; Steinhelper, ME | 1 |
| Garay, RP; Senn, N | 1 |
| Bachelet, M; Béréziat, G; Kadiri, C; Masliah, J; Vargaftig, BB | 1 |
| O'Flaherty, JT; Rossi, AG | 1 |
| Bommelaer-Bayet, MC; Dray, F; Gerozissis, K; Junier, MP; Rougeot, C; Saadi, M; Tiberghien, C; Wisner, A | 1 |
| Burch, RM; Tiffany, CW | 1 |
| Phillips, WA; Stewart, AG | 1 |
| Ibbotson, GC; Wallace, JL | 1 |
| Benveniste, J; Brink, C; Brunelleschi, S; Fantozzi, R; Giotti, A; Ledda, F; Renzi, D | 1 |
| Borgeat, P; Braquet, P; Harczy, M; Maclouf, J; Pradelles, P; Sirois, P | 2 |
| Felsen, D; Freund, RM; Vaughan, ED; Weisman, SM | 1 |
| Caravella, SJ; Clark, DA; McNeill, H; Miller, MJ; Mullane, KM | 1 |
| Errasfa, M; Fradin, A; Poincelot-Canton, B; Rothhut, B; Russo-Marie, F | 1 |
| Nakamura, T; Nishizawa, Y; Sato, T; Yamato, C | 1 |
| Badr, KF; DeBoer, DK; Fogo, A; Harris, RC; Jacobson, HR; Takahashi, K | 1 |
| Jancar, S; Sirois, P; Thériault, P | 1 |
| Hellewell, PG; Williams, TJ | 1 |
| Dahl, ML | 1 |
| Hassid, A; Kreisberg, JI | 1 |
| Klein-Knoeckel, D; Zimmerman, GA | 1 |
| DeCandido, S; Satriano, JA; Schlondorff, D | 1 |
| Chen, WY; Ko, WC; Ouyang, CH; Teng, CM | 1 |
| Csonka-Khalifah, L; Maguire, MH | 1 |
| Braquet, P; Neuwirth, R; Satriano, JA; Schlondorff, D; Singhal, P | 1 |
| Vandongen, R | 1 |
| Altin, JG; Bygrave, FL | 1 |
| Maclouf, J; Pradelles, P; Robidoux, C; Sirois, P | 1 |
| Beck, G; Brzozowski, T; Drozdowicz, D; Konturek, SJ | 1 |
| Clay, K; Diamond, B; Hays, RM; Lobmeyer, L; Neuwirth, R; Schlondorff, D; Singhal, P | 1 |
| Rosenbaum, JT; Rubin, RM | 1 |
| Rosenbaum, JT; Rubin, RM; Samples, JR | 1 |
| Pitcock, JA | 1 |
| Kelly, RW; Smith, SK | 1 |
| Arroyave, JL; Gonzalez-Crussi, F; Hsueh, W | 1 |
| Angle, MJ; McManus, LM; Pinckard, RN | 1 |
| Steel, G; Wallace, JL; Whittle, BJ | 2 |
| Benveniste, J; Brink, C; Brunelleschi, S; Haye-Legrand, I; Labat, C; Norel, X | 1 |
| Braquet, P; Pignol, B; Pouliot, C; Rola-Pleszczynski, M | 1 |
| Kogo, H; Matsudaira, T; Satoh, T | 1 |
| Felsen, D; Vaughan, ED; Weisman, SM | 1 |
| Archer, CB; MacDonald, DM; Morley, J; Page, CP; Paul, W | 2 |
| Abdel-Latif, AA; Yousufzai, SY | 1 |
| Anceschi, MM; Ban, C; Billah, MM; Bleasdale, JE; Di Renzo, GC; Hoffman, DR; Johnston, JM; Truong, CT | 1 |
| Archer, CB; Frohlich, W; MacDonald, DM; Morley, J; Page, CW; Paul, W | 1 |
| Kumahara, Y; Masugi, F; Ogihara, T; Otsuka, A; Saeki, S | 2 |
| Goto, S; Masugi, F; Ogihara, T; Otsuka, A; Tabuchi, Y | 1 |
| Issekutz, AC | 1 |
| Baud, L; Hagege, J; Perez, J; Satriano, JA; Schlondorff, D | 1 |
| Basran, GS; McGivern, DV | 1 |
| Beaubien, BB; Morris, HR; Tippins, JR | 1 |
| Benveniste, J; Drapier, JC; Petit, JF; Roubin, R | 1 |
| Capen, CC; Horton, JE; McCauley, LK; Nohutcu, RM; Rosol, TJ | 1 |
| Jaworek, J; Konturek, SJ | 1 |
| Autore, G; Capasso, F; Di Carlo, G; Di Urno, MV; Izzo, AA; Mascolo, N | 1 |
| Fujii, E; Irie, K; Muraki, T; Ohba, K; Uchida, Y | 1 |
| Conroy, MC; Finkel, M; Grabow, D; Lesch, M; Low, J; Metz, A; Schrier, D; Sommers, C; Wallace, J | 1 |
| Fortier, MA; Kim, JJ | 1 |
| Keuskamp, ZJ; Madretsma, GS; Van Dijk, JP; Zijlstra, FJ | 1 |
| Levi-Schaffer, F; Slavin, S; Vourka-Karussis, U | 1 |
| Collins, PD; Connolly, DT; Williams, TJ | 1 |
| Hellewell, PG; Teixeira, MM; Williams, TJ | 1 |
| Chandel, B; Deshpande, Y; Kaminski, DL; Kulkarni, A; Longo, WE; Niehoff, M; Polities, G; Vernava, AM | 1 |
| Chen, XS; Funk, CD; Griffis, G; Kurre, U | 1 |
| Arribas-Gómez, I; Díez-Marqués, ML; Duque-Marín, I; Lucio-Cazaña, J; Pérez de Lema, G; Rodríguez-Puyol, D; Rodríguez-Puyol, M | 1 |
| Rola-Pleszczynski, M; Thivierge, M | 2 |
| Bueno, L; Delvaux, M; Frexinos, J; Jeanneton, O | 1 |
| Coffman, TM; Goulet, JL; Koller, BH; Latour, AM; Snouwaert, JN | 1 |
| Botella, A; Bueno, L; Delvaux, M; Frexinos, J; Jeanneton, O | 1 |
| Autore, G; Capasso, F; Di Carlo, G; Izzo, AA; Maiello, FM; Mascolo, N | 1 |
| Asmis, R; Dennis, EA | 2 |
| Gillin, AG | 1 |
| Chandel, B; Deshpande, Y; Kaminski, DL; Li, AP; Longo, WE; Stratton, MD; Vernava, AM | 1 |
| Autore, G; Capasso, F; Izzo, AA; Mascolo, N | 1 |
| Argenbright, LW; Norman, KE; Rossi, AG; Williams, TJ | 1 |
| de la Cruz, C; de Nicoläs, R; Egido, J; González, E; Herrero-Beaumont, G | 1 |
| Ackerman, Z; Eliakim, R; Karmeli, F; Rachmilewitz, D; Stalnikowicz, R | 1 |
| Balsinde, J; Barbour, SE; Bianco, ID; Dennis, EA | 1 |
| Chen, LL; Kreutzer, DL; Mann, EA; Spiro, JD | 1 |
| Turnberg, LA; Wardle, TD | 1 |
| Goff, AK; Slama, H; Vaillancourt, D | 2 |
| Green, PG; Heller, P; Levine, JD; Luo, J | 1 |
| Beusenberg, FD; Bonta, IL; van Amsterdam, JG | 1 |
| Ahluwalia, A; Perretti, M | 1 |
| Asmis, R; Dennis, EA; Randriamampita, C; Tsien, RY | 1 |
| Jafari, HS; McCracken, GH | 1 |
| Cabré, F; Carganico, G; Gutiérrez, M; Mauleón, D; Suesa, N; Tost, D; Ucedo, P | 1 |
| Tjebbes, GW; van Delft, JL; van Haeringen, NJ | 1 |
| Anglin, C; Carson, R; Clapp, N; Fretland, D; Hansard, R; Henke, M; Walsh, R; Widomski, D | 1 |
| Levine, BA; Olson, MS; Zhou, W | 1 |
| Barlow, R; Barr, RM; Courtney, P; Greaves, MW; Judge, MR; Kobza Black, A; Lawlor, F; Mallet, AI | 1 |
| Chen, BN; McLoughlin, JW; Menadue, MF; Norman, RJ; Oliver, JR; Rayner, TE | 1 |
| Katz, S; Mok, W; Phaneuf, S; Salari, H; Wong, S | 1 |
| Egido, J; Gómez-Guerrero, C; González, E; Hernando, P; Ruiz-Ortega, M | 1 |
| Blair, IA; Christman, BW; Christman, JW; Dworski, R; Prakash, C | 1 |
| Alami, N; de Brum-Fernandes, AJ; Müller, E; Rola-Pleszczynski, M; Thivierge, M | 1 |
| Braquet, P; Jager, GV; van Delft, JL; van Haeringen, NJ; Verbeij, NL | 1 |
| Jones, RL; Matthews, JS | 1 |
| Amore, A; Bocchietto, E; Bussolino, F; Cavallo, F; Coppo, R; Gianoglio, B; Peruzzi, L; Porcellini, MG | 1 |
| Boll, RM; Gustafson-Svärd, C; Kald, B; Tagesson, C | 1 |
| Bazan, HE; Hurst, JS | 1 |
| Adamson, SL; Bishai, I; Coceani, F; Engelberts, D; House, RV | 1 |
| Mue, S; Ohuchi, K; Watanabe, M; Yamada, M | 3 |
| Ganbo, T; Hisamatsu, K; Inoue, H; Kikushima, K; Murakami, Y; Nakajima, M | 1 |
| Hall, L; Turnberg, LA; Wardle, TD | 1 |
| Goto, Y; Ishimaru, S; Izaki, S; Kitamura, K; Matsuzaki, M; Yamamoto, T; Yudate, F | 1 |
| Egido, J; González, E; Gutierrez, S; Herrero-Beaumont, G; Miguélez, R; Navarro, F; Palacios, I; Sanchez-Pernaute, O | 1 |
| Church, MK; Hatzelmann, A; Schudt, C; Shute, JK; Tenor, H | 1 |
| Calignano, A; Cozzolino, A; Mancuso, F; Metafora, S; Porta, R | 1 |
| Asano, G; Ohtani, N | 1 |
| Andrade, LE; Jancar, S; Rocha, FA; Russo, M | 1 |
| Fang, GD; Guerrant, RL; Marcinkiewicz, M; Sarosiek, J; Thielman, NM | 1 |
| Friebe, WG; Scheuer, W; Thierse, HJ; Tibes, U; Voelter, W | 1 |
| al-Rashed, S; Hellewell, PG; Rossi, AG; Teixeira, MM | 1 |
| Berends, C; de Monchy, JG; Dijkhuizen, B; Dubois, AE; Gerritsen, J; Kauffman, HF | 1 |
| Delalandre, A; Filep, JG; Földes-Filep, E; Payette, Y | 1 |
| López-Novoa, JM; Martínez-Salgado, C; Pérez de Lema, G; Rodríguez-Barbero, A; Rodríguez-Puyol, D | 1 |
| Fortin, D; Gaumond, F; Rola-Pleszczynski, M; Stankova, J | 1 |
| Asano, K; Bitoh, H; Imaki, H; Kurokawa, K; Nakao, A; Nosaka, K; Shimizu, T; Suzuki, T; Taniguchi, S; Watanabe, T | 1 |
| Erickson, KL; Howard, AD; Hubbard, NE | 1 |
| Bindi, D; Ciuffi, M; Franchi-Micheli, S; Maurizi, M; Mugnai, S; Zilletti, L | 1 |
| Bratton, DL; Fadok, VA; Freed, PW; Henson, PM; Konowal, A; Westcott, JY | 1 |
| Berón de Astrada, M; Chaud, MA; Franchi, AM; Gimeno, MF | 1 |
| Wise, H | 1 |
| Alper, CM; Burckart, GJ; Diven, WF; Doyle, WJ; Evans, RW; Jaffe, R | 1 |
| Ichinowatari, G; Ohuchi, K; Tanimoto, A; Yaginuma, H; Yamada, M | 2 |
| Shirasawa, E; Tsuji, F | 1 |
| Barber, LA; Dy, LC; Fertel, RH; Johnson, CA; Kelley, SW; Murphy, RC; Nguyen, TM; Pei, Y; Travers, JB; Williams, DA | 1 |
| Bos, JL; Coffer, P; Franke, B; Koenderman, L; M'Rabet, L; Segal, AW; Zwartkruis, F | 1 |
| Denizot, Y; Praloran, V; Trimoreau, F | 1 |
| Ito, K; Nakagawa, T; Tadokoro, K; Takafuji, S | 1 |
| Ding, JS; He, JL; Li, HP; Quan, CJ | 1 |
| Bueno, L; Delisle, MB; Delvaux, M; Frexinos, J; Jeanneton, O; Langlois, Y; Le Bars, J; Le Bars, P | 1 |
| Beadle, RE; Holmes, EP; Seahorn, TL; Venugopalan, CS | 1 |
| Coghe, J; Deby-Dupont, G; Lekeux, P; Uystepruyst, C; Van de Weerdt, ML | 1 |
| Alonso, A; Bayón, Y; Hernández, M; Nieto, ML; Sánchez Crespo, M | 1 |
| Denizot, Y; Feiss, P; Nathan, N | 1 |
| Alvi, SA; Bennett, PR; Brown, NL; Elder, MG; Sullivan, MH | 1 |
| Alvi, SA; Bennett, PR; Brown, NL; Elder, MG; Rajasingam, D; Sullivan, MH | 1 |
| Chambers, EL; Downing, SJ; Leese, HJ; Maguiness, SD; Watson, A | 1 |
| Alpert, SE; Bourbon, N; Kester, M; Mandal, A; Walenga, RW | 1 |
| Friedman, M; Kafoury, RM; Pryor, WA; Salgo, MG; Squadrito, GL; Zou, X | 1 |
| Barbour, SE; Best, AM; Ishihara, Y; Quinn, SM; Schenkein, HA; Tew, JG; Zhang, JB | 1 |
| Bardhan, KD; Brown, NJ; Jacob, S; Kalia, N; Reed, MW | 1 |
| Denizot, Y; Godard, A; Praloran, V; Raher, S; Trimoreau, F | 1 |
| Sakai, H; Suzuki, T; Takeguchi, N | 1 |
| Jancar, S; Lonardoni, MV; Russo, M | 1 |
| Enomoto, A; Gelb, MH; Ghomashchi, F; Koduri, RS; Kudo, I; Lambeau, G; Murakami, M; Seki, M; Shimbara, S; Singer, A; Valentin, E; Yoshihara, K | 1 |
| Benfield, T; Cowan, MJ; Logun, C; Shelhamer, JH; Tavakoli, S | 1 |
| Fietzner, K; Fink, L; Grimminger, F; Hattar, K; Himmel, B; Seeger, W; Sibelius, U | 1 |
| Banville, J; Brassil, PJ; Burke, JR; Davern, LB; Gregor, KR; Johnson, G; Remillard, R; Russell, JW; Stanley, PL; Tramposch, KM; Tredup, JA; Witmer, MR | 1 |
| Barrera, N; Hermoso, M; Morales, B; Pérez, S; Villalón, M | 1 |
| Ichinowatari, G; Ohuchi, K; Tanimoto, A; Tsuyuki, K; Yaginuma, H; Yamada, M | 1 |
| Chow, KC; Wang, LS; Wu, YC | 1 |
| Lee, RK; Teather, LA; Wurtman, RJ | 1 |
| Göggel, R; Hoffman, S; Narumiya, S; Nüsing, R; Uhlig, S | 1 |
| Teather, LA; Wurtman, RJ | 1 |
| Gandhi, CR; Harvey, SA; Yang, Y | 1 |
| Behar, J; Biancani, P; Guarino, MP; Xiao, ZL | 1 |
| Awong, G; Cuvelier, SL; Iqbal, SM; Patel, KD; Tibbles, LA; Wierzbicki, T | 1 |
| Beck-Speier, I; Dayal, N; Denzlinger, C; Haberl, C; Heyder, J; Maier, KL; Ziesenis, A | 1 |
| Abran, D; Beauchamp, M; Bouayad, A; Chemtob, S; Clyman, RI; Fouron, JC; Hou, X; Peri, K; Quiniou, C; Varma, DR | 1 |
| Kazimi, N; Nghiem, DX; Ramos, G; Ullrich, SE; Walterscheid, JP | 1 |
| Bate, C; Salmona, M; Williams, A | 1 |
| Bate, C; Reid, S; Williams, A | 1 |
| Jancar, S; Ribeiro-Dias, F; Shio, MT; Timenetsky, J | 1 |
| Atilla, G; Başkesen, A; Berdeli, AH; Buduneli, E; Buduneli, N; Türkoğlu, O; Vardar, S | 1 |
| Atilla, G; Başkesen, A; Baylas, H; Berdeli, AH; Buduneli, E; Türkoğlu, O; Vardar, S | 1 |
| Atilla, G; Baylas, H; Berdeli, AH; Buduneli, E; Buduneli, N; Vardar, S | 1 |
| Behar, J; Biancani, P; Cao, W; Cheng, L; Fiocchi, C; Harnett, KM | 1 |
| Bazan, NG; Chen, C | 1 |
| Chang, GT; Chang, YC; Chung, KH; Kang, SK; Kim, CH; Kim, JH | 1 |
| Engel, S; Göggel, R; Uhlig, S | 1 |
| Abele, H; Akel, A; Attanasio, P; Bachmann, C; Bachmann, R; Gatz, S; Hermle, T; Huber, S; Kempe, DS; Lang, F; Lang, PA; Podolski, M; Shumilina, E; Wieder, T | 1 |
| Barreto-de-Souza, V; Bou-Habib, DC; Bozza, PT; Castro-Faria-Neto, HC; Lima, RG; Moreira, L; Paes-Leme, J | 1 |
| Calixto, JB; Henriques, Md; Kassuya, CA; Menezes-de-Lima, O; Nascimento, AF | 1 |
| Borgeat, P; Bourgoin, SG; Flamand, N; Lemieux, L; Picard, S; Pouliot, M | 1 |
| Seltmann, H; Travers, JB; Zhang, Q; Zouboulis, CC | 1 |
| Borgeat, M; Borgeat, P; Hattermann, K; Leclerc, P; Picard, S; Pouliot, M | 1 |
| Clandinin, MT; Ma, DW; Park, EJ; Ramanujam, K; Suh, M; Thomson, AB; Thomson, B | 1 |
| Boedker, M; Boetkjaer, A; Cui, JG; Lukiw, WJ; Zhao, Y | 1 |
| Dong, CZ; Dutertre-Catella, H; Ezoulin, MJ; Heymans, F; Liu, Z; Massicot, F; Ombetta, JE; Rat, P; Wu, G | 1 |
| Kato, H; Kojima, F; Matsushita, M; Naraba, H; Narumiya, S; Oh-Ishi, S; Sugimoto, Y; Ueno, A; Ushikubi, F; Yuhki, K | 1 |
| Bauer, JE; Horohov, DW; Hosgood, G; LeBlanc, CJ; Mauldin, GE | 1 |
| McHowat, J; Rastogi, P; Young, DM | 1 |
| Krüger, B; Löhrke, B; Vernunft, A; Viergutz, T; Xu, J | 1 |
| Cai, Y; Chen, L; Jiang, X; Tian, H; Wu, C; Xu, R; Ye, Q; Yuan, W; Zhang, X | 1 |
| Bao, GQ; Ju, AZ | 1 |
| Sharif, NA; Wiernas, TK | 1 |
| Fox, SC; Glenn, JR; Heptinstall, S; Iyú, D; Johnson, AJ; White, AE | 1 |
| Musto, AE; Samii, M | 1 |
| Faxvaag, A; Feuerherm, AJ; Johansen, B; Leistad, L | 1 |
| Fischlein, T; Förch, S; Juchem, G; Knott, M; Kreuzer, E; Laufer, S; Nees, S; Reichart, B; Senftl, A; Weiss, DR | 1 |
| Perelman, B; Vadas, P | 1 |
| Jalil, J; Jantan, I; Jasamai, M; Saadawi, S | 1 |
| FitzGerald, GA; Kaplan, MH; Ocana, JA; Pawelzik, SC; Romer, E; Sahu, R; Travers, JB | 1 |
| Gu, X; Jiao, Y; Liu, M; Ma, Z; Qi, M; Shi, X; Xie, X; Zhang, T; Zhou, L | 1 |
13 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dinoprostone
| Article | Year |
|---|---|
[Mediators of inflammation and hemorrhagic rectocolitis].
Topics: Arachidonic Acids; Colitis, Ulcerative; Dinoprost; Dinoprostone; Eicosanoids; Gastrointestinal Motility; Humans; Leukotriene B4; Platelet Activating Factor | 1991 |
Prostaglandin E2, leukotriene C4, and platelet-activating factor receptor sites in the brain. Binding parameters and pharmacological studies.
Topics: Animals; Brain; Dinoprostone; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Immunologic; Receptors, Leukotriene; Receptors, Prostaglandin; Receptors, Prostaglandin E; SRS-A | 1989 |
Interactions of arachidonic acid metabolites and platelet activating factor and mechanism of action in hypersensitivity reactions.
Topics: Animals; Arachidonic Acids; Dinoprostone; Diterpenes; Eicosanoic Acids; Enzyme Activation; Ginkgolides; Guinea Pigs; Hypersensitivity; Inflammation; Lactones; Leukotriene B4; Lung; Muscle Contraction; Phospholipases; Phospholipases A; Platelet Activating Factor; Prostaglandins E; SRS-A; Thromboxane B2 | 1987 |
Functional properties of glomerular cells in culture.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Calcium; Cell Adhesion; Cells, Cultured; Contractile Proteins; Cyclic AMP; Diabetes Mellitus; Dinoprostone; Epithelial Cells; Glomerular Mesangium; Glomerulonephritis; Humans; Kidney Glomerulus; Platelet Activating Factor; Prostaglandins; Prostaglandins E; Rats | 1986 |
Morphometric studies of the renomedullary interstitial cells.
Topics: Animals; Blood Pressure; Cytoplasmic Granules; Dinoprostone; Hypertension; Hypertension, Renovascular; Kidney Medulla; Lipids; Platelet Activating Factor; Prostaglandins E | 1988 |
Role of polymorphonuclear leukocytes in the vascular responses of acute inflammation.
Topics: Acute Disease; Animals; Blood Coagulation Factors; Capillary Permeability; Chemotactic Factors; Cricetinae; Dinoprostone; Epoprostenol; Inflammation; Neutrophils; Platelet Activating Factor; Prostaglandins E; Rabbits; Vasomotor System | 1984 |
Regulation of prostaglandin E2 production in P388D1 macrophage-like cells.
Topics: Animals; Dinoprostone; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Phospholipids; Platelet Activating Factor; Signal Transduction | 1994 |
Maintenance of high risk pregnancies: role of prostaglandins and other mediators.
Topics: Dinoprostone; Female; Humans; Labor Onset; Obstetric Labor, Premature; Platelet Activating Factor; Pre-Eclampsia; Pregnancy; Pregnancy, High-Risk; Tocolysis | 1994 |
Dexamethasone therapy in bacterial meningitis.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Cytokines; Dexamethasone; Dinoprostone; Drug Therapy, Combination; Endotoxins; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Meningitis, Bacterial; Platelet Activating Factor | 1994 |
Mechanisms of cell signaling in immune-mediated inflammation.
Topics: Anaphylatoxins; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Chemokines; Chemotactic Factors; Dinoprostone; GTP-Binding Proteins; Immunoglobulin G; Inflammation; Leukocytes; Leukotriene B4; Leukotrienes; Lipids; Mice; Models, Biological; NF-kappa B; Phagocytes; Phospholipases A; Platelet Activating Factor; Signal Transduction; Thromboxane A2 | 1998 |
Lipid signaling: sleep, synaptic plasticity, and neuroprotection.
Topics: Animals; Cannabinoid Receptor Modulators; Dinoprostone; Fatty Acids; Hippocampus; Humans; Lipid Metabolism; Memory; Models, Biological; Neuronal Plasticity; Neurons; Neuroprotective Agents; Platelet Activating Factor; Prostaglandin D2; Signal Transduction; Synapses; Synaptic Transmission | 2005 |
Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung.
Topics: Animals; Ceramides; Dinoprostone; Endothelium, Vascular; Humans; Leukotrienes; Lung; Permeability; Platelet Activating Factor; Thromboxane A2 | 2005 |
[Signal pathways of eryptosis-review].
Topics: Apoptosis; Dinoprostone; Erythrocytes; Humans; Platelet Activating Factor; Signal Transduction | 2009 |
5 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dinoprostone
| Article | Year |
|---|---|
Effect of duodenal ulcer healing induced by omeprazole and ranitidine on the generation of gastroduodenal eicosanoids, platelet-activating factor, pepsinogen A, and gastrin in duodenal ulcer patients.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Dinoprostone; Duodenal Ulcer; Eicosanoids; Female; Gastrins; Humans; Intestinal Mucosa; Leukotrienes; Male; Middle Aged; Omeprazole; Pepsinogens; Platelet Activating Factor; Random Allocation; Ranitidine | 1992 |
Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation.
Topics: Dinoprostone; Double-Blind Method; Histamine Release; Humans; Inflammation; Injections, Intradermal; Male; Pain; Platelet Activating Factor; Prostaglandins E; Sensory Thresholds; Skin Tests | 1987 |
Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Diclofenac; Dinoprostone; Double-Blind Method; Female; Humans; Interleukin-1; Interleukin-6; Knee Joint; Leukotriene B4; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Osteoarthritis; Platelet Activating Factor; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 1994 |
The effect of nizatidine on duodenal ulcer healing and on mucosal inflammatory mediators.
Topics: Adult; Aged; Dinoprostone; Double-Blind Method; Duodenal Ulcer; Female; Gastric Mucosa; Gastroscopy; Humans; Leukotriene B4; Leukotriene C4; Male; Middle Aged; Nizatidine; Platelet Activating Factor; Radioimmunoassay; Risk Factors | 1994 |
Ketoprofen and phenylbutazone attenuation of PAF-induced lung inflammation in calves.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cattle Diseases; Dinoprostone; Ketoprofen; Leukotriene B4; Male; Phenylbutazone; Placebos; Platelet Activating Factor; Pneumonia; Respiration; Thromboxane B2 | 1999 |
254 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dinoprostone
| Article | Year |
|---|---|
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved.
Topics: Animals; Aprotinin; Blood Coagulation Factors; Bradykinin; Complement C5a; Dinoprostone; Edema; Fluoroacetates; Histamine Antagonists; Immunoglobulin E; Indomethacin; Lipoxygenase Inhibitors; Male; Neutrophils; Oligopeptides; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Quinolines; Rabbits; Specific Pathogen-Free Organisms | 1992 |
Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits.
Topics: Animals; Arthritis; Arthritis, Experimental; Azepines; Dinoprostone; Drug Synergism; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thienopyridines; Tumor Necrosis Factor-alpha | 1992 |
Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions.
Topics: Alveolitis, Extrinsic Allergic; Animals; Azepines; Bronchoalveolar Lavage Fluid; Dinoprostone; Diterpenes; Econazole; Ginkgolides; Hemoglobins; Hemorrhage; Indomethacin; Lactones; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Propionates; Quinolines; Rats; Rats, Inbred Strains; Thromboxanes; Triazoles | 1992 |
Protein tyrosine phosphorylation and regulation of the receptor for platelet-activating factor in rat Kupffer cells. Effect of sodium vanadate.
Topics: Animals; Dinoprostone; Genistein; Isoflavones; Kinetics; Kupffer Cells; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sensitivity and Specificity; Stimulation, Chemical; Temperature; Time Factors; Vanadates | 1992 |
Stimulation of cyclic AMP production in human alveolar macrophages induced by inflammatory mediators and beta-sympathicomimetics.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Cyclic AMP; Dinoprostone; Female; Histamine; Humans; Isoproterenol; Lung Diseases, Obstructive; Macrophages, Alveolar; Male; Middle Aged; Platelet Activating Factor; Smoking | 1992 |
Effects of complement activation on platelet-activating factor and eicosanoid synthesis in rat mesangial cells.
Topics: Acetyltransferases; Animals; Cells, Cultured; Complement Activation; Dinoprostone; Eicosanoids; Elapid Venoms; Glomerular Mesangium; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1992 |
Immunoregulatory functions of paf-acether. VIII. Inhibition of IL-4-induced human IgE synthesis in vitro.
Topics: Dinoprostone; Humans; Immunoglobulin E; Immunoglobulin M; In Vitro Techniques; Interferon-gamma; Interleukin-4; Leukocytes, Mononuclear; Platelet Activating Factor; RNA, Messenger; Transforming Growth Factor beta | 1992 |
The effects of platelet-activating factor (PAF) and a PAF antagonist (CV-3988) on smoke inhalation injury in an ovine model.
Topics: Animals; Dinoprostone; Lipid Peroxidation; Male; Malondialdehyde; Phospholipid Ethers; Platelet Activating Factor; Platelet Count; Sheep; Smoke Inhalation Injury; Thromboxane B2; Time Factors | 1992 |
Effects of platelet-activating factor on prostaglandin E2 production by intact fetal membranes.
Topics: Amnion; Chorion; Decidua; Dinoprostone; Female; Humans; Labor, Obstetric; Platelet Activating Factor; Pregnancy; Time Factors | 1992 |
Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils.
Topics: Azepines; Calcimycin; Calcium; Cytosol; Dinoprostone; Eosinophils; Histamine; Histamine Antagonists; Humans; In Vitro Techniques; Lung; Mast Cells; Neutrophils; Piperidines; Platelet Activating Factor; Prostaglandin D2; Secretory Rate; SRS-A; Triazoles | 1992 |
Inflammatory effects of platelet activating factor (PAF) in equine skin.
Topics: Animals; Capillary Permeability; Chlorpheniramine; Dermatitis; Dinoprostone; Dose-Response Relationship, Drug; Histamine; Horse Diseases; Horses; Indomethacin; Injections, Intradermal; Leukocyte Count; Neutrophils; Platelet Activating Factor; Regional Blood Flow; Skin; Skin Temperature | 1992 |
Platelet-activating factor stimulates production of prostaglandin E2 in murine osteoblast-like cell line MC3T3-E1.
Topics: Animals; Cell Line; Dinoprostone; Dose-Response Relationship, Drug; Mice; Osteoblasts; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Time Factors | 1991 |
The effect of lipoproteins on the release of some eicosanoids by stimulated human leukocytes. A possible role in atherogenesis.
Topics: Arachidonic Acid; Calcimycin; Dextran Sulfate; Dinoprostone; Fatty Acids; Humans; Hydroxyeicosatetraenoic Acids; Leukocytes; Leukotriene B4; Lipoproteins, LDL; Platelet Activating Factor | 1991 |
Involvement of lipid mediators in the pathogenesis of experimental nephrosis in rats: its pharmacological modulation.
Topics: Animals; Dinoprostone; Doxorubicin; Kidney Glomerulus; Lipoxygenase Inhibitors; Male; Nephrosis, Lipoid; Platelet Activating Factor; Platelet Membrane Glycoproteins; Proteinuria; Random Allocation; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane B2 | 1991 |
Inflammatory mediators in cotton-top tamarins (CTT) with acute and chronic colitis.
Topics: Acute Disease; Animals; Chronic Disease; Colitis; Dinoprostone; Disease Models, Animal; Histamine; Interleukin-1; Leukotriene B4; Peroxidase; Platelet Activating Factor; Saguinus | 1991 |
Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Capillary Permeability; Complement C5a; Dinoprostone; Drug Synergism; Edema; Histamine H1 Antagonists; In Vitro Techniques; Interleukin-1; Male; Neutrophils; Platelet Activating Factor; Protein Synthesis Inhibitors; Rabbits; Triazoles | 1991 |
Endotoxin-induced impairment of vascular reactivity in the pithed rat: role of arachidonic acid metabolites.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Cyclooxygenase Inhibitors; Dinoprostone; Electric Stimulation; Endotoxins; Epoprostenol; Flurbiprofen; Hemodynamics; Iloprost; Male; Norepinephrine; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Strains; Spinal Cord; Sympathetic Nervous System | 1990 |
Site of anti-inflammatory action of dexamethasone in rabbit skin.
Topics: Animals; Bradykinin; Dactinomycin; Dermatitis, Contact; Dexamethasone; Dinoprostone; Female; Histamine; Leukotriene B4; Male; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Protein Biosynthesis; Rabbits; RNA; Skin; Zymosan | 1991 |
A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat.
Topics: Anaphylaxis; Animals; Azepines; Biological Transport; Carbazoles; Dinoprostone; Electrolytes; Female; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Jejunum; Leukotriene Antagonists; Leukotrienes; Phospholipids; Platelet Activating Factor; Propionates; Quinolines; Rats; Thromboxanes; Triazoles | 1992 |
Mechanisms of platelet-activating factor-induced electrolyte transport in the rat jejunum.
Topics: Animals; Arachidonic Acids; Azepines; Biological Transport, Active; Chlorides; Dinoprostone; Eicosanoic Acids; Electrophysiology; Female; Indomethacin; Jejunum; Platelet Activating Factor; Quinacrine; Rats; Triazoles | 1991 |
A role of peripheral leukocytes in vascular permeability and edema formation in air pouch type allergic inflammation in rats.
Topics: Animals; Capillary Permeability; Chemotaxis, Leukocyte; Cyclophosphamide; Dinoprostone; Edema; Hypersensitivity; In Vitro Techniques; Inflammation; Leukocyte Count; Leukocytes; Male; Neutrophils; Platelet Activating Factor; Rats; Rats, Inbred Strains; Serotonin; SRS-A | 1991 |
Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea.
Topics: Adult; Dinoprost; Dinoprostone; Dysmenorrhea; Female; Humans; Menstrual Cycle; Platelet Activating Factor; SRS-A | 1991 |
PAF receptor mediated PGE2 production in LPS primed P388D1 macrophage-like cells.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cycloheximide; Cyclooxygenase Inhibitors; Dactinomycin; Dinoprostone; Enzyme Activation; Gene Expression Regulation, Neoplastic; Genistein; Isoflavones; Lipopolysaccharides; Macrophages; Mice; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandin-Endoperoxide Synthases; Protein-Tyrosine Kinases; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction; Tumor Cells, Cultured | 1991 |
A product of activated human granulocytes stimulates prostaglandin E2 synthesis in human amnion cells.
Topics: Amnion; Cells, Cultured; Chorioamnionitis; Cytochalasin B; Dinoprostone; Epidermal Growth Factor; Female; Free Radical Scavengers; Granulocytes; Hot Temperature; Humans; Indomethacin; Labor, Obstetric; N-Formylmethionine Leucyl-Phenylalanine; Obstetric Labor, Premature; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pregnancy; Protein Synthesis Inhibitors; Stimulation, Chemical | 1991 |
Gastric bleeding and increased gastric vascular permeability induced by platelet activating factor (PAF): effect of drugs that affect arachidonate metabolism.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Caffeic Acids; Capillary Permeability; Dinoprostone; Gastric Mucosa; Gastrointestinal Hemorrhage; Hydrocortisone; Imidazoles; Indomethacin; Male; Perfusion; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1991 |
Platelet-activating factor induces nonspecific desensitization to bronchodilators in guinea pigs.
Topics: Airway Resistance; Animals; Desensitization, Immunologic; Dihydroalprenolol; Dinoprostone; Drug Interactions; Guinea Pigs; Isoproterenol; Lung; Male; Methacholine Chloride; Platelet Activating Factor; Tritium | 1991 |
[The effect of interleukin-1 on ocular inflammation in rabbit ocular tissue].
Topics: Animals; Aqueous Humor; Dinoprostone; Disease Models, Animal; Endophthalmitis; Eye Proteins; Indomethacin; Interleukin-1; Phospholipid Ethers; Platelet Activating Factor; Rabbits | 1991 |
Leukotrienes in brain: natural occurrence and induced changes.
Topics: Administration, Oral; Animals; Arachidonic Acid; Body Temperature; Brain Chemistry; Cats; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Cyclooxygenase Inhibitors; Dinoprostone; Female; In Vitro Techniques; Injections, Intraventricular; Leukotrienes; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Pyrogens; Radioimmunoassay; Thromboxane B2 | 1991 |
Release of platelet activating factor by the isolated kidney is not linked to the production of prostaglandins.
Topics: Angiotensin II; Animals; Bradykinin; Calcimycin; Dinoprostone; In Vitro Techniques; Kidney; Male; Perfusion; Platelet Activating Factor; Prostaglandins; Rats; Rats, Inbred Strains; Renal Veins; Stimulation, Chemical; Vascular Resistance | 1991 |
Effects of prostaglandin E2 and cyclooxygenase inhibitors on clustering and level of nicotinic acetylcholine receptor in mouse myotubes co-cultured with spinal cord explant.
Topics: Animals; Aspirin; Cell Communication; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Embryo, Mammalian; Indomethacin; Kinetics; Masoprocol; Mice; Mice, Inbred Strains; Muscles; Organ Culture Techniques; Platelet Activating Factor; Receptors, Nicotinic; Spinal Cord | 1991 |
Renal and femoral vascular responses to endothelin-1 in dogs: role of prostaglandins.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Dinoprostone; Dogs; Dose-Response Relationship, Drug; Endothelins; Female; Femoral Artery; Heart Rate; Infusions, Intra-Arterial; Infusions, Intravenous; Kidney; Male; Platelet Activating Factor; Prostaglandins; Pyridinium Compounds; Renal Circulation; Time Factors; Vasoconstriction | 1991 |
Paracrine interactions between platelet-activating factor and prostaglandins in hormonally-treated human luteal phase endometrium in vitro.
Topics: Cells, Cultured; Dinoprostone; Endometrium; Estradiol; Female; Gonadal Steroid Hormones; Humans; Luteal Phase; Platelet Activating Factor; Progesterone; Prostaglandins; Prostaglandins E; Prostaglandins F | 1991 |
Enhancement of thrombin- and ionomycin-stimulated prostacyclin and platelet-activating factor production in cultured endothelial cells by a tumor-promoting phorbol ester.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Arachidonic Acids; Calcimycin; Cells, Cultured; Dinoprost; Dinoprostone; Endothelium, Vascular; Epoprostenol; Humans; Ionomycin; Isoquinolines; Phorbol Esters; Phospholipases A; Phospholipases A2; Piperazines; Platelet Activating Factor; Prostaglandin D2; Prostaglandins H; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Thrombin | 1990 |
Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2.
Topics: Animals; Arachidonic Acids; Calcimycin; Cell Line; Dactinomycin; Diglycerides; Dinoprostone; Kinetics; Lipopolysaccharides; Macrophages; Models, Biological; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1990 |
Identification of prostaglandin E2 and leukotriene B4 in the synovial fluid of painful, dysfunctional temporomandibular joints.
Topics: Cartilage, Articular; Dinoprostone; Female; Humans; Joint Dislocations; Leukotriene B4; Male; Platelet Activating Factor; Synovial Fluid; Synovitis; Temporomandibular Joint Dysfunction Syndrome | 1990 |
Regulation of platelet-activating factor receptor and platelet-activating factor receptor-mediated biological responses by cAMP in rat Kupffer cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Bucladesine; Cells, Cultured; Colforsin; Cyclic AMP; Dinoprostone; Isoproterenol; Kinetics; Kupffer Cells; Phenylephrine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane B2 | 1990 |
Effect of CV-3988, a specific antagonist against platelet activating factor, on homologous passive cutaneous anaphylaxis in the mouse ear.
Topics: Alprostadil; Animals; Antibodies; Blood Vessels; Dinoprostone; Ear, External; Female; Histamine; Immunoglobulin E; Immunoglobulin G; Leukotriene E4; Mice; Mice, Inbred BALB C; Passive Cutaneous Anaphylaxis; Permeability; Phospholipid Ethers; Platelet Activating Factor; Serotonin; Skin; SRS-A | 1990 |
Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
Topics: Animals; Dinoprostone; Diterpenes; Endotoxins; Escherichia coli; Ginkgolides; Lactones; Male; Plant Extracts; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock, Septic; Thromboxane B2 | 1990 |
Inflammatory mediators are involved in the Candida albicans killing activity of human epidermal cells.
Topics: Candida albicans; Dexamethasone; Dinoprostone; Diterpenes; Epidermal Cells; Epidermis; Ginkgolides; Humans; Indomethacin; Inflammation; Interleukin-1; Lactones; Phagocytosis; Platelet Activating Factor; Recombinant Proteins; Ultraviolet Rays | 1990 |
Insulin-dependent contractility of glomerular mesangial cells in response to angiotensin II, platelet-activating factor and endothelin is attenuated by prostaglandin E2.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Angiotensin II; Animals; Calcium; Cells, Cultured; Dinoprostone; Endothelins; Glomerular Mesangium; Indomethacin; Insulin; Kidney Cortex; Kinetics; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1990 |
Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin.
Topics: Blotting, Western; Cell Line; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Endotoxins; Humans; In Vitro Techniques; Interleukin-1; Lipopolysaccharides; Monocytes; Platelet Activating Factor | 1990 |
Predominant functional roles for thromboxane A2 and prostaglandin E2 during late nephrotoxic serum glomerulonephritis in the rat.
Topics: Animals; Blood Pressure; Dinoprost; Dinoprostone; Glomerular Filtration Rate; Glomerulonephritis; Hematocrit; Male; Platelet Activating Factor; Proteinuria; Rats; Thromboxane A2; Vascular Resistance | 1990 |
Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts.
Topics: Animals; Cyclosporins; Dinoprostone; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunization; Male; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred ACI; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Heterologous; Transplantation, Heterotopic | 1990 |
Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability.
Topics: Animals; Bradykinin; Calcitonin Gene-Related Peptide; Capillary Permeability; Complement C5; Complement C5a, des-Arginine; Dinoprostone; Drug Synergism; Edema; Histamine; Inflammation; Injections, Intradermal; Leukotriene B4; Male; N-Formylmethionine Leucyl-Phenylalanine; Nerve Tissue Proteins; Platelet Activating Factor; Prostaglandins E; Rabbits; Rats; Rats, Inbred Lew; Skin; Species Specificity; Substance P | 1985 |
Potent inhibition of leukotriene (LT) B4 release from human polymorphonuclear leukocytes (PMN) by the PGE1-analogue OP-1206.
Topics: Alprostadil; Dinoprostone; Epoprostenol; Humans; Iloprost; In Vitro Techniques; Leukotriene B4; Neutrophils; Platelet Activating Factor; Prostaglandins E, Synthetic | 1988 |
Effect of topical capsaicin on the cutaneous responses to inflammatory mediators and to antigen in man.
Topics: Administration, Topical; Adult; Allergens; Capsaicin; Dinoprostone; Double-Blind Method; Histamine Release; Humans; Hypersensitivity; Hypersensitivity, Immediate; Neuropeptides; Platelet Activating Factor | 1989 |
Differential activation of human skin cells by platelet activating factor: stimulation of phosphoinositide turnover and arachidonic acid mobilization in keratinocytes but not in fibroblasts.
Topics: Adult; Arachidonic Acids; Cells, Cultured; Dinoprostone; Epidermis; Fibroblasts; Humans; Inositol; Inositol Phosphates; Keratins; Kinetics; Phosphatidylinositols; Platelet Activating Factor; Skin | 1989 |
Relationship of GTP-binding proteins, phospholipase C, and PGE2 synthesis in rat glomerular mesangial cells.
Topics: Angiotensin II; Animals; Calcimycin; Dinoprostone; Glomerular Mesangium; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Inositol Phosphates; Platelet Activating Factor; Rats; Thionucleotides; Type C Phospholipases | 1989 |
Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosadienoic acid, and p-bromophenacyl bromide.
Topics: Acetophenones; Calcimycin; Cell Line; Dinoprostone; Fatty Acids, Unsaturated; Kinetics; Macrophages; Melitten; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Substrate Specificity; Terpenes | 1989 |
The effects of TMB-8 on the shape changes of vascular endothelial cells resulting from exposure to various inflammatory agents.
Topics: Animals; Bradykinin; Calcimycin; Calcium Channel Blockers; Dinoprostone; Endothelium, Vascular; Gallic Acid; Guinea Pigs; Histamine; In Vitro Techniques; Inflammation; Leukotrienes; Platelet Activating Factor; Vena Cava, Inferior | 1989 |
Prostaglandin production by cultured cynomolgus monkey trabecular meshwork cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Bradykinin; Calcimycin; Cells, Cultured; Dexamethasone; Dinoprost; Dinoprostone; Humans; Macaca fascicularis; Platelet Activating Factor; Prostaglandins; Radioimmunoassay; Trabecular Meshwork | 1989 |
Lipid mediator production by post-implantation rat embryos in vitro.
Topics: Alprostadil; Animals; Cells, Cultured; Dinoprostone; Embryo, Mammalian; Embryonic Development; Female; Gestational Age; Leukotrienes; Lipid Metabolism; Platelet Activating Factor; Pregnancy; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Inbred Strains; Thromboxane B2 | 1989 |
Vascular responses to leukocyte products in atherosclerotic primates.
Topics: Animals; Arteries; Arteriosclerosis; Dinoprostone; Epoprostenol; Hemodynamics; Leukocyte Count; Leukocytes; Lipids; Macaca fascicularis; Male; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; SRS-A; Vasoconstrictor Agents | 1989 |
Release of cyclooxygenase products from primary cultures of tracheal epithelia of dog and human.
Topics: Animals; Bradykinin; Calcimycin; Cells, Cultured; Dinoprost; Dinoprostone; Dogs; Epithelium; Gas Chromatography-Mass Spectrometry; Humans; Isoproterenol; Kinetics; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Species Specificity; SRS-A; Thromboxane B2; Trachea | 1989 |
Release of eicosanoids in rat peritoneal cavity during the Arthus reaction. Effect of the PAF-antagonist BN-52021 and indomethacin.
Topics: Animals; Arthus Reaction; Dinoprostone; Diterpenes; Ginkgolides; Guinea Pigs; Indomethacin; Lactones; Leukotriene B4; Male; Peritoneal Cavity; Platelet Activating Factor; Rats; Rats, Inbred Strains; Thromboxane B2 | 1989 |
Interactions between cyclic AMP stimulating drugs and PAF-acether in guinea-pig alveolar macrophages.
Topics: Albuterol; Animals; Arachidonic Acids; Cyclic AMP; Dinoprostone; Drug Interactions; Guinea Pigs; In Vitro Techniques; Macrophages; Platelet Activating Factor; Pulmonary Alveoli | 1989 |
Platelet activating factor is a potent colonic secretagogue with actions independent of specific PAF receptors.
Topics: Animals; Bradykinin; Calcium; Colon; Cyclooxygenase Inhibitors; Dinoprostone; Electrophysiology; Furosemide; Intestinal Mucosa; Male; Muscle, Smooth; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Time Factors | 1989 |
Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages.
Topics: Animals; Annexins; Calcimycin; Dexamethasone; Dinoprostone; Glycoproteins; Guinea Pigs; Humans; Macrophages; Mice; NADH, NADPH Oxidoreductases; NADPH Oxidases; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pulmonary Alveoli; Recombinant Proteins; Superoxides | 1989 |
Beta 2-adrenergic agonist regulation of immune aggregate- and platelet-activating factor-stimulated hepatic metabolism.
Topics: Animals; Antigen-Antibody Complex; Bucladesine; Dinoprostone; Glycogen; Isoproterenol; Liver; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Thromboxane B2; Vasoconstriction | 1989 |
Regulation of Na+ and K+ contents in rat thymocytes.
Topics: Animals; Biological Transport; Blood Coagulation Factors; Bumetanide; Dinoprostone; Hypertension; Isoproterenol; Kinetics; Male; Ouabain; Platelet Activating Factor; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY; Sodium; Sodium Channels; T-Lymphocytes | 1989 |
Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
Topics: Animals; Dinoprostone; Diterpenes; Fatty Acids, Unsaturated; Ginkgolides; Lactones; Leukotriene B4; Peritoneal Cavity; Platelet Activating Factor; Rats; Rats, Inbred Strains; Thromboxane B2 | 1989 |
Phospholipase A2-mediated release of arachidonic acid in stimulated guinea pig alveolar macrophages: interaction with lipid mediators and cyclic AMP.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acids; Bronchoalveolar Lavage Fluid; Calcimycin; Cyclic AMP; Dinoprostone; Guinea Pigs; Lipid Metabolism; Lipids; Macrophages; N-Formylmethionine Leucyl-Phenylalanine; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Pulmonary Alveoli; Tetradecanoylphorbol Acetate; Thromboxane B2 | 1989 |
Prostaglandin binding sites in human polymorphonuclear neutrophils.
Topics: Dinoprost; Dinoprostone; Humans; Leukotriene B4; Neutrophils; Platelet Activating Factor; Prostaglandin D2; Prostaglandins; Receptors, Prostaglandin | 1989 |
Tumor necrosis factor causes amplification of arachidonic acid metabolism in response to interleukin 1, bradykinin, and other agonists.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Bombesin; Bradykinin; Cell Line; Dexamethasone; Dinoprostone; Interleukin-1; Mice; Norepinephrine; Phospholipases A; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Receptors, Cell Surface; Thrombin; Tumor Necrosis Factor-alpha | 1989 |
Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Azepines; Calcimycin; Chromatography, High Pressure Liquid; Culture Media; Dinoprostone; Eicosanoids; Guinea Pigs; In Vitro Techniques; Macrophages; Male; N-Formylmethionine Leucyl-Phenylalanine; Peritoneal Cavity; Platelet Activating Factor; Superoxides; Triazines; Triazoles | 1989 |
Beneficial effects of prostaglandin E2 in endotoxic shock are unrelated to effects on PAF-acether synthesis.
Topics: Animals; Capillary Permeability; Dinoprostone; Duodenum; Gastric Mucosa; Lung; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock, Septic; Stomach | 1989 |
Interference of WEB 2086 and BN 52021 with Paf-induced effects on guinea-pig trachea.
Topics: Animals; Azepines; Dinoprostone; Diterpenes; Ginkgolides; Guinea Pigs; Histamine Antagonists; In Vitro Techniques; Lactones; Male; Muscle Relaxation; Muscle, Smooth; Platelet Activating Factor; Trachea; Triazines; Triazoles | 1989 |
Inhibition of the release of prostaglandins, thromboxanes, and leukotrienes from anaphylactic lungs by a platelet-activating factor (PAF) antagonist and its stimulation by PAF.
Topics: 6-Ketoprostaglandin F1 alpha; Anaphylaxis; Animals; Dinoprostone; Fatty Acids, Unsaturated; Guinea Pigs; In Vitro Techniques; Leukotriene B4; Lung; Platelet Activating Factor; Prostaglandins E; SRS-A; Thromboxane B2 | 1987 |
Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction.
Topics: Angiotensin II; Animals; Benzofurans; Dinoprostone; Kidney; Lignans; Male; Peptides; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandins; Prostaglandins E; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane B2; Triazolam; Ureteral Obstruction | 1988 |
Interaction between PAF-acether and drugs that stimulate cyclic AMP in guinea-pig alveolar macrophages.
Topics: Albuterol; Animals; Arachidonic Acid; Arachidonic Acids; Cell Adhesion; Cyclic AMP; Dinoprostone; Female; Guinea Pigs; In Vitro Techniques; Macrophages; Male; Platelet Activating Factor; Prostaglandins E; Pulmonary Alveoli | 1988 |
SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Depression, Chemical; Dinoprostone; Disease Models, Animal; Enterocolitis, Pseudomembranous; Leukotriene B4; Leukotrienes; Male; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Prostaglandins; Rabbits; Superoxide Dismutase; Thromboxane B2 | 1988 |
Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'.
Topics: Annexins; Calcimycin; Dexamethasone; Dinoprostone; Glycoproteins; Humans; Inflammation; Kinetics; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Activating Factor | 1988 |
Inflammatory mechanisms in the Arthus reaction.
Topics: Animals; Antigen-Antibody Complex; Arthus Reaction; Complement C5; Complement C5a; Dinoprostone; Edema; Histamine H1 Antagonists; Inflammation; Male; Neutrophils; Platelet Activating Factor; Prostaglandins E; Rabbits | 1986 |
Effect of azelastine on the intracellular Ca2+ mobilization in guinea pig peritoneal macrophages.
Topics: Animals; Calcium; Cells, Cultured; Dinoprostone; Guinea Pigs; Histamine H1 Antagonists; Ketotifen; Macrophages; Male; N-Formylmethionine Leucyl-Phenylalanine; Peritoneal Cavity; Phthalazines; Platelet Activating Factor; Prostaglandins E; Pyridazines | 1988 |
Glomerular responses to platelet-activating factor in the rat: role of thromboxane A2.
Topics: Animals; Blood Pressure; Dinoprostone; Glomerular Filtration Rate; Hemodynamics; Kidney Glomerulus; Male; Platelet Activating Factor; Rats; Thromboxane A2; Ultrafiltration | 1989 |
Effect of PAF on selected smooth muscle preparations.
Topics: Animals; Dinoprostone; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1989 |
A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin.
Topics: Animals; Arthus Reaction; Capillary Permeability; Chemotactic Factors; Chemotaxis, Leukocyte; Dinoprostone; Edema; Furans; Immunosuppressive Agents; Male; Platelet Activating Factor; Prostaglandins E; Rabbits; Skin | 1986 |
Aggregating and prostanoid-releasing effects of platelet-activating factor and leukotrienes on human polymorphonuclear leukocytes and platelets.
Topics: Cell Aggregation; Dinoprostone; Humans; Leukotriene B4; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; SRS-A; Thromboxane B2 | 1985 |
Human endothelial cells inhibit granulocyte aggregation in vitro.
Topics: Blood Coagulation Factors; Cell Aggregation; Cells, Cultured; Dinoprostone; Endothelium; Epoprostenol; Granulocytes; Humans; In Vitro Techniques; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Platelet Aggregation; Prostaglandins E; SRS-A | 1986 |
Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung.
Topics: Anaphylaxis; Animals; Arachidonic Acid; Arachidonic Acids; Dinoprostone; Diterpenes; Female; Ginkgolides; Guinea Pigs; In Vitro Techniques; Kinetics; Lactones; Lung; Male; Ovalbumin; Plant Extracts; Platelet Activating Factor; Prostaglandins; Prostaglandins E; Thromboxane B2; Thromboxanes | 1986 |
Different concentrations of pertussis toxin have opposite effects on agonist-induced PGE2 formation in mesangial cells.
Topics: Angiotensin II; Animals; Calcimycin; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; GTP-Binding Proteins; In Vitro Techniques; Kidney Glomerulus; Membrane Proteins; Molecular Weight; NAD; Pertussis Toxin; Platelet Activating Factor; Prostaglandins E; Rats; Virulence Factors, Bordetella | 1986 |
Antiplatelet effect of butylidenephthalide.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Blood Coagulation Factors; Calcimycin; Collagen; Dinoprostone; Guinea Pigs; Humans; In Vitro Techniques; Phthalic Acids; Phthalic Anhydrides; Platelet Activating Factor; Platelet Aggregation; Prostaglandins E; Rabbits; Thrombin; Thromboxane B2 | 1987 |
Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Chromatography, Thin Layer; Cyclooxygenase Inhibitors; Dinoprostone; Humans; In Vitro Techniques; Malondialdehyde; Microsomes; Oxygen Consumption; Platelet Activating Factor; Platelet Aggregation; Prostaglandins E; Thromboxane B2; Vinblastine | 1987 |
Effect of platelet activating factor antagonists on cultured rat mesangial cells.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Benzofurans; Calcimycin; Cells, Cultured; Dinoprostone; Diterpenes; Dose-Response Relationship, Drug; Ginkgolides; Glomerular Mesangium; Lactones; Lignans; Male; Plant Extracts; Platelet Activating Factor; Prostaglandins E; Rats; Thiazoles | 1987 |
Vasodepressor phospholipids in reversal of renal hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antihypertensive Agents; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Dinoprostone; Hypertension, Renovascular; Phospholipases A; Phospholipids; Platelet Activating Factor; Prostaglandins E; Rats | 1987 |
Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Dinoprost; Dinoprostone; Glucagon; In Vitro Techniques; Liver; Male; Oxygen Consumption; Phenylephrine; Platelet Activating Factor; Prostaglandin D2; Prostaglandins D; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains; Thromboxane A2; Vasoconstriction | 1988 |
Release of prostaglandin E2 and thromboxane B2 by mixed isolated human lung cells.
Topics: Bradykinin; Calcimycin; Cells, Cultured; Dinoprostone; Humans; Immunoenzyme Techniques; Lung; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Prostaglandins E; Tetradecanoylphorbol Acetate; Thromboxane B2 | 1988 |
Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-activating factor and stress in rats.
Topics: Animals; Aspirin; Chromones; Dinoprostone; Ethanol; Female; Gastric Mucosa; Male; Platelet Activating Factor; Prostaglandins E; Rats; Rats, Inbred Strains; SRS-A; Stomach Ulcer; Stress, Physiological; Taurocholic Acid | 1988 |
Evidence for immunoglobulin Fc receptor-mediated prostaglandin2 and platelet-activating factor formation by cultured rat mesangial cells.
Topics: Animals; Antigen-Antibody Complex; Cells, Cultured; Dinoprostone; Glomerular Mesangium; Gold; Gold Radioisotopes; Immunoglobulin G; Platelet Activating Factor; Prostaglandins E; Rats; Receptors, Fc; Rosette Formation; Serum Albumin, Bovine | 1988 |
A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation.
Topics: Animals; Aqueous Humor; Capillary Permeability; Dinoprostone; Eye; Female; Flurbiprofen; Inflammation; Interleukin-1; Leukocyte Count; Platelet Activating Factor; Prednisolone; Prostaglandins E; Proteins; Quinolinium Compounds; Rabbits; Recombinant Proteins | 1988 |
Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-activating factor antagonist.
Topics: Animals; Anterior Chamber; Aqueous Humor; Capillary Permeability; Dexamethasone; Dinoprostone; Drug Synergism; Endophthalmitis; Endotoxins; Eye; Female; Indomethacin; Platelet Activating Factor; Prostaglandins E; Punctures; Quinolinium Compounds; Rabbits | 1988 |
Effect of platelet-activating factor on the release of PGF-2 alpha and PGE-2 by separated cells of human endometrium.
Topics: Cells, Cultured; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Endometrium; Female; Humans; Platelet Activating Factor; Prostaglandins E; Prostaglandins F | 1988 |
Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor.
Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Chromones; Dinoprostone; Indomethacin; Intestine, Small; Methacrylates; Perfusion; Platelet Activating Factor; Prostaglandins E; Rats; SRS-A; Thromboxane B2; Vasoconstriction | 1986 |
Age-dependent differential development of leukotactic and vasoactive responsiveness to acute inflammatory mediators.
Topics: Aging; Animals; Blood; Bradykinin; Capillary Permeability; Chemotaxis, Leukocyte; Dinoprostone; Female; Histamine; Inflammation; Kinetics; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Prostaglandins E; Rabbits; Zymosan | 1986 |
Failure of prostaglandin E2 and its 16,16-dimethyl analogue to prevent the gastric mucosal damage induced by Paf.
Topics: 16,16-Dimethylprostaglandin E2; Administration, Oral; Animals; Blood Pressure; Capillary Permeability; Dinoprostone; Ethanol; Injections, Intravenous; Male; Platelet Activating Factor; Prostaglandins E; Prostaglandins E, Synthetic; Rats; Rats, Inbred Strains; Stomach Ulcer | 1987 |
Gastrointestinal plasma leakage in endotoxic shock. Inhibition by prostaglandin E2 and by a platelet-activating factor antagonist.
Topics: Animals; Blood Pressure; Blood Proteins; Digestive System; Dinoprostone; Male; Phospholipid Ethers; Platelet Activating Factor; Prostaglandins E; Rats; Rats, Inbred Strains; Serum Albumin, Bovine; Shock, Septic; Thiazoles | 1987 |
Platelet-activating factor-acether-induced relaxation of guinea pig airway muscle: role of prostaglandin E2 and the epithelium.
Topics: Acetylcholine; Animals; Aspirin; Dinoprostone; Epithelium; Guinea Pigs; Histamine; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Norepinephrine; Platelet Activating Factor; Prostaglandins E; Serotonin; SRS-A; Thromboxane B2; Trachea | 1987 |
Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021.
Topics: Adult; Cells, Cultured; Dinoprostone; Diterpenes; Ginkgolides; Humans; Indomethacin; Interleukin-2; Lactones; Lymphocyte Activation; Lymphocytes; Phytohemagglutinins; Plant Extracts; Platelet Activating Factor; Prostaglandins E; Thromboxane B2 | 1987 |
A possible role of antihypertensive polar renomedullary lipid (APRL) and prostaglandin E2 in the kidney in the antihypertensive action of pindolol.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dinoprostone; Electrolytes; Indomethacin; Kidney; Male; Phospholipid Ethers; Pindolol; Platelet Activating Factor; Prostaglandins E; Rats; Rats, Inbred SHR; Thiazoles | 1985 |
Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction.
Topics: Animals; Biological Assay; Dinoprostone; Dose-Response Relationship, Drug; Kidney; Male; Perfusion; Platelet Activating Factor; Prostaglandins; Prostaglandins E; Rabbits; Rats; Stomach; Thromboxane B2; Time Factors; Ureteral Obstruction | 1985 |
Inflammatory characteristics of PAF-acether in the skin of experimental animals and man.
Topics: Animals; Dinoprostone; Humans; Inflammation; Platelet Activating Factor; Prostaglandins E; Skin Tests | 1985 |
Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Calcium Channel Blockers; Dinoprostone; Dose-Response Relationship, Drug; Female; Iris; Male; Microsomes; Muscle, Smooth; Phosphatidylinositols; Platelet Activating Factor; Prostaglandins; Prostaglandins E; Rabbits; Time Factors | 1985 |
Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor.
Topics: Amnion; Calcimycin; Calcium; Dinoprostone; Egtazic Acid; Female; Humans; Labor, Obstetric; Platelet Activating Factor; Pregnancy; Prostaglandins E | 1985 |
Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man.
Topics: Animals; Cardiovascular Agents; Dinoprostone; Drug Synergism; Epoprostenol; Guinea Pigs; Humans; Iloprost; Platelet Activating Factor; Prostaglandins E; Serum Albumin; Skin | 1984 |
The role of antihypertensive polar renomedullary lipid in the pathogenesis of hypertension.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dinoprostone; Dogs; Epoprostenol; Female; Histamine; Hypertension, Renal; Kidney; Kidney Medulla; Male; Norepinephrine; Phospholipid Ethers; Platelet Activating Factor; Prostaglandins E; Rats; Rats, Inbred Strains; Thiazoles | 1984 |
[Renomedullary hypotensive lipids and prostaglandins].
Topics: Adult; Aging; Animals; Blood Pressure; Dinoprostone; Dogs; Epoprostenol; Humans; Hypertension; Kidney Medulla; Male; Platelet Activating Factor; Prostaglandins E | 1983 |
Effect of platelet-activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release, and contraction of cultured rat mesangial cells.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Glomerular Mesangium; Phagocytosis; Platelet Activating Factor; Prostaglandins E; Rats; Zymosan | 1984 |
Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin.
Topics: Adult; Dermatitis, Contact; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Humans; Injections, Subcutaneous; Platelet Activating Factor; Prostaglandins E; Skin | 1984 |
Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man.
Topics: Adult; Anti-Inflammatory Agents; Dinoprostone; Drug Synergism; Female; Humans; Male; Platelet Activating Factor; Prostaglandins E; Skin | 1984 |
Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide.
Topics: Animals; Dinoprostone; Indomethacin; Lung; Male; Platelet Activating Factor; Prostaglandins E; Rats; Rats, Inbred Strains; SRS-A; Vasoactive Intestinal Peptide | 1984 |
The role of immunomodulators in the production of lipid mediators by macrophages (M phi).
Topics: Animals; Arachidonic Acids; Dinoprostone; In Vitro Techniques; Macrophages; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Prostaglandins; Prostaglandins E; SRS-A | 1984 |
Potent hypotensive activity of 1-O-hexadecyl-2-O-acetyl-SN-glycero-3-phosphocholine in spontaneously hypertensive rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Hypertension; Kinetics; Lysophosphatidylcholines; Male; Platelet Activating Factor; Prostaglandins E; Rats; Rats, Inbred Strains | 1982 |
Effects of hormones and cytokines on stimulation of adenylate cyclase and intracellular calcium concentration in human and canine periodontal-ligament fibroblasts.
Topics: Adenylyl Cyclases; Adult; Animals; Calcitonin; Calcitonin Gene-Related Peptide; Calcium; Carrier Proteins; Cells, Cultured; Cyclic AMP; Cyclic AMP Receptor Protein; Cytokines; Dinoprostone; Dogs; Fibroblasts; Hormones; Humans; Interleukin-1; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Periodontal Ligament; Platelet Activating Factor; Proteins; Stimulation, Chemical; Substance P; Transforming Growth Factor beta | 1993 |
Effects of prostaglandin of E, F and I series, leukotriene C and platelet activating factor on amylase release from isolated rat pancreatic acini.
Topics: Acetamides; Amylases; Animals; Bethanechol Compounds; Ceruletide; Chromones; Dinoprostone; Epoprostenol; Indomethacin; Isoquinolines; Leukotriene C4; Male; Pancreas; Phenyl Ethers; Platelet Activating Factor; Prostaglandin Antagonists; Prostaglandins; Prostaglandins F; Prostaglandins F, Synthetic; Pyridinium Compounds; Rats; Rats, Wistar; Tetrahydroisoquinolines | 1993 |
Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents.
Topics: Animals; Bradykinin; Carrageenan; Cellulose; Dextrans; Dinoprostone; Diterpenes; Drug Synergism; Edema; Ginkgolides; Histamine; Inflammation Mediators; Lactones; Male; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Rats; Rats, Wistar; Serotonin; Verapamil | 1994 |
Role of eicosanoids but not nitric oxide in the platelet-activating factor-induced increase in vascular permeability in mouse skin.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Capillary Permeability; Cyclooxygenase Inhibitors; Dinoprostone; Eicosanoids; In Vitro Techniques; Indomethacin; Male; Mice; Mice, Inbred Strains; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Skin | 1995 |
Cytoprotective effects of CI-959 in the rat gastric mucosa: modulation of leukocyte adhesion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Cell Adhesion; Dinoprostone; Dogs; Ethanol; Female; Gastric Acid; Gastric Mucosa; Histamine Antagonists; Indomethacin; Leukocytes; Leukotriene C4; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sulfhydryl Compounds; Tetrazoles; Thiophenes | 1995 |
Cell type specificity and protein kinase C dependency on the stimulation of prostaglandin E2 and prostaglandin F2 alpha production by oxytocin and platelet-activating factor in bovine endometrial cells.
Topics: Animals; Cattle; Cells, Cultured; Dinoprost; Dinoprostone; Endometrium; Female; Oxytocin; Platelet Activating Factor; Prostaglandins; Protein Kinase C; Stimulation, Chemical; Tachyphylaxis; Tetradecanoylphorbol Acetate; Time Factors | 1995 |
Nicotine inhibits cytokine synthesis by mouse colonic mucosa.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Colitis, Ulcerative; Colon; Cytokines; Dinoprostone; Female; Interleukin-1; Intestinal Mucosa; Leukotriene B4; Leukotriene C4; Mice; Mice, Inbred BALB C; Nicotine; Platelet Activating Factor; Prostaglandins; Thromboxane B2; Tumor Necrosis Factor-alpha | 1995 |
Investigations on the role of inflammatory and anti-inflammatory agents on the treatment of murine B cell leukemia by recombinant human interleukin-2.
Topics: Animals; Anti-Inflammatory Agents; Bradykinin; Dinoprostone; Freund's Adjuvant; Histamine; Inflammation; Interleukin-2; Leukemia, B-Cell; Lipopolysaccharides; Mice; Mice, Inbred BALB C; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Recombinant Proteins; Substance P | 1993 |
Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo.
Topics: Animals; Aprotinin; Bradykinin; Capillary Permeability; Dinoprostone; Endothelial Growth Factors; Heparin; Histamine Antagonists; Humans; In Vitro Techniques; Inflammation; Iodine Radioisotopes; Lymphokines; Male; Neutrophils; Platelet Activating Factor; Rabbits; Recombinant Proteins; Skin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilator Agents | 1993 |
E-type prostaglandins enhance local oedema formation and neutrophil accumulation but suppress eosinophil accumulation in guinea-pig skin.
Topics: Alprostadil; Animals; Dinoprostone; Edema; Eosinophils; Guinea Pigs; Iloprost; In Vitro Techniques; Indium Radioisotopes; Isoproterenol; Male; Neutrophils; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Prostaglandins E; Skin; Zymosan | 1993 |
Platelet-activating factor mediates trinitrobenzene induced colitis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Colitis; Colon; Dinoprostone; Eicosanoids; Gastrointestinal Contents; Leukotriene B4; Platelet Activating Factor; Rabbits; Second Messenger Systems; Thromboxane B2; Triazoles; Trinitrobenzenesulfonic Acid | 1994 |
Leukotriene-deficient mice generated by targeted disruption of the 5-lipoxygenase gene.
Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Bone Marrow Cells; Carrageenan; Dinoprostone; Female; Inflammation; Leukotriene C4; Leukotrienes; Macrophages; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Mutant Strains; Phagocytosis; Phenotype; Platelet Activating Factor; Spleen; Tetradecanoylphorbol Acetate | 1995 |
A possible role for platelet-activating factor in the hydrogen peroxide-induced TXB2 and PGE2 glomerular synthesis.
Topics: Animals; Cells, Cultured; Dinoprostone; Hydrogen Peroxide; Kidney Glomerulus; Platelet Activating Factor; Rats; Rats, Wistar; Thromboxane B2 | 1995 |
Up-regulation of inducible cyclooxygenase gene expression by platelet-activating factor in activated rat alveolar macrophages.
Topics: Animals; Dinoprostone; Gene Expression Regulation, Enzymologic; In Vitro Techniques; Kinetics; Macrophages, Alveolar; Male; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; RNA, Messenger; Transcription, Genetic; Up-Regulation | 1995 |
Desensitization of platelet-activating factor receptors, induced by inflammation in guinea pig ileal smooth muscle cells.
Topics: Acetylcholine; Animals; Cell Survival; Dinoprostone; Diterpenes; Ginkgolides; Guinea Pigs; Ileitis; Ileum; Indomethacin; Lactones; Male; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Prostaglandin E; Trinitrobenzenesulfonic Acid | 1995 |
Altered inflammatory responses in leukotriene-deficient mice.
Topics: Anaphylaxis; Animals; Arachidonate 5-Lipoxygenase; Chemotaxis, Leukocyte; Dinoprostone; Edema; Inflammation; Leukotriene C4; Leukotrienes; Macrophages; Mice; Mice, Knockout; Neutrophils; Platelet Activating Factor; Thromboxane B2 | 1994 |
Homologous desensitization of PAF receptors via a PGE2-dependent pathway on intestinal smooth muscle.
Topics: Acetophenones; Animals; Dinoprostone; Guinea Pigs; Ileum; Indomethacin; Kinetics; Male; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandins; Receptors, Cell Surface; Receptors, Cholecystokinin; Receptors, G-Protein-Coupled; Receptors, Prostaglandin E; Sensitivity and Specificity; Sincalide; Time Factors | 1994 |
Acetic acid-induced colitis in normal and essential fatty acid deficient rats.
Topics: Acetates; Acetic Acid; Acid Phosphatase; Animals; Colitis; Dietary Fats; Dinoprostone; Fatty Acids; Leukotriene B4; Male; Platelet Activating Factor; Rats; Rats, Wistar | 1995 |
The effect of Clostridium difficile toxin on colonocyte prostanoid activity.
Topics: 6-Ketoprostaglandin F1 alpha; Bacterial Proteins; Bacterial Toxins; Cell Line, Transformed; Colon; Culture Media; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Humans; Indomethacin; Leukotriene B4; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Thromboxane B2 | 1994 |
Platelet activating factor and the responses of rat isolated stomach strip to prostaglandin E2.
Topics: Acetylcholine; Animals; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Rats, Wistar; Serotonin; Stomach | 1993 |
Role of adhesion glycoproteins CD18 and intercellular adhesion molecule-1 in complement-mediated reactions of rabbit skin.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Arthus Reaction; Bradykinin; CD18 Antigens; Cell Adhesion Molecules; Dinoprostone; Dogs; Edema; Hemorrhage; Humans; Intercellular Adhesion Molecule-1; Mice; Platelet Activating Factor; Rabbits; Receptors, Leukocyte-Adhesion; Skin; Zymosan | 1994 |
Arachidonic acid mobilization in P388D1 macrophages is controlled by two distinct Ca(2+)-dependent phospholipase A2 enzymes.
Topics: Animals; Arachidonic Acid; Base Sequence; Cell Line; Dinoprostone; DNA Primers; DNA, Antisense; Gene Expression; Macrophages; Membrane Lipids; Mice; Molecular Sequence Data; Phospholipases A; Phospholipases A2; Phospholipids; Platelet Activating Factor; RNA, Messenger; Time Factors | 1994 |
PAF stimulates cAMP formation in P388D1 macrophage-like cells via the formation and secretion of prostaglandin E2 in an autocrine fashion.
Topics: Animals; Cell Line; Cyclic AMP; Cyclooxygenase Inhibitors; Dinoprostone; Inositol 1,4,5-Trisphosphate; Isoquinolines; Lipopolysaccharides; Mice; Models, Biological; Platelet Activating Factor; Signal Transduction; Sulfonamides | 1994 |
Phospholipid metabolite expression by head and neck squamous cell carcinoma.
Topics: Aged; Analysis of Variance; Animals; Carcinoma, Squamous Cell; Dinoprostone; Epidermal Growth Factor; Evaluation Studies as Topic; Fibroblasts; Head and Neck Neoplasms; Humans; Immune Tolerance; Interleukin-1; Leukotriene B4; Lipopolysaccharides; Middle Aged; Neoplasm Staging; Phenotype; Platelet Activating Factor; Radioimmunoassay; Regression Analysis; Tumor Cells, Cultured | 1994 |
Involvement of both cyclooxygenase and lipoxygenase pathways in platelet-activating factor-induced interleukin-6 production by alveolar macrophages.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Arachidonate 5-Lipoxygenase; Aspirin; Bucladesine; Cyclooxygenase Inhibitors; Dinoprostone; Ibuprofen; Indomethacin; Interleukin-6; Leukotriene B4; Macrophages, Alveolar; Male; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 1994 |
Potential role for interleukin-1 in the pathophysiology of ulcerative colitis.
Topics: Adult; Animals; Colitis, Ulcerative; Colon; Culture Media; Culture Techniques; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; Interleukin-1; Intestinal Mucosa; Leukotriene C4; Male; Middle Aged; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Quinacrine; Rats; Rats, Sprague-Dawley | 1994 |
Control of in vitro prostaglandin F2 alpha and E2 synthesis by caruncular and allantochorionic tissues from cows that calved normally and those with retained fetal membranes.
Topics: Allantois; Animals; Calcium; Cattle; Cattle Diseases; Chorion; Culture Techniques; Dinoprost; Dinoprostone; Epidermal Growth Factor; Estradiol; Extraembryonic Membranes; Female; Labor Stage, Third; Obstetric Labor Complications; Oxytocin; Placenta; Platelet Activating Factor; Pregnancy; Protein Kinase C | 1994 |
Modulation of bradykinin-induced plasma extravasation in the rat knee joint by sympathetic co-transmitters.
Topics: Adenosine; Adenosine Triphosphate; Animals; Antihypertensive Agents; Arginine; Arthritis; Bradykinin; Dinoprostone; Male; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Phenethylamines; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Sympathetic Nervous System | 1993 |
Cyclic-AMP level and eicosanoid release from alveolar macrophages are differentially affected by high and low dose of platelet activating factor.
Topics: Animals; Cyclic AMP; Dinoprostone; Dose-Response Relationship, Drug; Guinea Pigs; Leukotriene B4; Macrophages, Alveolar; Male; Platelet Activating Factor | 1994 |
Anti-inflammatory effect of prostanoids in mouse and rat skin: evidence for a role of EP3-receptors.
Topics: Alprostadil; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood; Dinoprostone; Edema; Male; Mice; Misoprostol; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, Prostaglandin E; Skin; Zymosan | 1994 |
Intracellular Ca2+, inositol 1,4,5-trisphosphate and additional signalling in the stimulation by platelet-activating factor of prostaglandin E2 formation in P388D1 macrophage-like cells.
Topics: Calcium; Cell Line; Dinoprostone; Egtazic Acid; Inositol 1,4,5-Trisphosphate; Ionomycin; Lipopolysaccharides; Macrophages; Pertussis Toxin; Platelet Activating Factor; Protein-Tyrosine Kinases; Signal Transduction; Virulence Factors, Bordetella | 1994 |
Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Blood Platelets; Calcimycin; Cells, Cultured; Dinoprostone; Endothelins; Endothelium, Vascular; Epoprostenol; Histamine; Humans; Hydroxyeicosatetraenoic Acids; Interleukin-1; Platelet Activating Factor; Platelet Aggregation; Prostaglandins; Serotonin; Thrombin; Tumor Necrosis Factor-alpha; Umbilical Veins | 1993 |
Production of lipid mediators in experimental keratitis of rabbit eye.
Topics: Animals; Aqueous Humor; Dinoprostone; Keratitis; Leukotrienes; Male; Platelet Activating Factor; Rabbits | 1993 |
Inflammatory mediator changes in cotton-top tamarins (CTT) after SC-41930 anti-colitic therapy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Benzopyrans; Colitis; Colon; Dinoprostone; Disease Models, Animal; Leukotriene B4; Platelet Activating Factor; Radioimmunoassay; Saguinus; Thromboxane B2 | 1993 |
Lipid mediator production in acute and chronic pancreatitis in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Chronic Disease; Dinoprostone; Diterpenes; Eicosanoids; Ginkgolides; Lactones; Leukotriene B4; Ligation; Male; Masoprocol; Pancreatic Ducts; Pancreatitis; Platelet Activating Factor; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Taurocholic Acid; Thromboxane B2 | 1994 |
Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Arachidonic Acid; Blister; Clobetasol; Dinoprostone; Exudates and Transudates; Female; Gas Chromatography-Mass Spectrometry; Humans; Lipid Metabolism; Male; Middle Aged; Platelet Activating Factor; Skin | 1993 |
Prostaglandin F2 alpha mediates platelet-activating factor-stimulated atrial natriuretic factor release from the isolated rat heart.
Topics: Animals; Atrial Natriuretic Factor; Dinoprost; Dinoprostone; Heart; Heart Rate; Indomethacin; Kinetics; Male; Meclofenamic Acid; Myocardial Contraction; Perfusion; Platelet Activating Factor; Prostaglandins E; Prostaglandins F; Rats | 1993 |
Metabolism of arachidonic acid by caruncular and allantochorionic tissues in cows with retained fetal membranes (RFM).
Topics: 6-Ketoprostaglandin F1 alpha; Allantois; Animals; Arachidonic Acid; Calcium; Cattle; Chorion; Chromatography, High Pressure Liquid; Dinoprost; Dinoprostone; Epidermal Growth Factor; Female; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Oxytocin; Placenta; Placenta Diseases; Platelet Activating Factor; Pregnancy; Thromboxane B2 | 1993 |
Forskolin inhibits platelet-activating factor binding to platelet receptors independently of adenylyl cyclase activation.
Topics: Adenylyl Cyclases; Animals; Blood Platelets; Cell Membrane; Colforsin; Cyclic AMP; Dinoprostone; Enzyme Activation; GTP-Binding Proteins; In Vitro Techniques; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1993 |
Interaction of mesangial cells with IgA and IgG immune complexes: a possible mechanism of glomerular injury in IgA nephropathy.
Topics: Antigen-Antibody Complex; Dinoprostone; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Inflammation; Myeloma Proteins; Platelet Activating Factor; Receptors, Fc; Receptors, Immunologic; Superoxides; Tumor Necrosis Factor-alpha | 1993 |
Prostaglandin E2 limits arachidonic acid availability and inhibits leukotriene B4 synthesis in rat alveolar macrophages by a nonphospholipase A2 mechanism.
Topics: Animals; Arachidonic Acid; Calcimycin; Dinoprostone; Leukotriene B4; Leukotrienes; Macrophages, Alveolar; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rats | 1993 |
Transcriptional modulation of platelet-activating factor receptor gene expression by cyclic AMP.
Topics: Animals; Azepines; Bucladesine; Calcium; Cell Membrane; Cells, Cultured; Cricetinae; Cyclic AMP; Cycloheximide; Dinoprostone; Flow Cytometry; Gene Expression Regulation; Humans; Kinetics; Monocytes; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Messenger; Transcription, Genetic; Triazoles | 1993 |
Antagonist of platelet-activating factor prevents prostaglandin E2 induced ocular hypertension in rabbits.
Topics: Animals; Dinoprostone; Diterpenes; Dose-Response Relationship, Drug; Ginkgolides; Intraocular Pressure; Kinetics; Lactones; Male; Platelet Activating Factor; Rabbits | 1993 |
Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Dinoprostone; Drug Synergism; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandin Endoperoxides, Synthetic; Prostaglandins E, Synthetic; Xanthenes; Xanthones | 1993 |
Cytokine mRNA expression by cultured rat mesangial cells after contact with environmental lectins.
Topics: Animals; Cells, Cultured; Cytokines; Dinoprostone; Gene Expression; Genes, fos; Genes, myc; Gliadin; Glomerular Mesangium; Interleukin-1; Interleukin-6; Lectins; Platelet Activating Factor; Rats; RNA, Messenger; Thromboxane B2; Tumor Necrosis Factor-alpha | 1993 |
Tumor necrosis factor-alpha potentiates phospholipase A2-stimulated release and metabolism of arachidonic acid in cultured intestinal epithelial cells (INT 407).
Topics: Arachidonic Acid; Calcimycin; Cell Line; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Epithelium; Humans; Intestinal Mucosa; Lipid Metabolism; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Type C Phospholipases | 1993 |
Platelet-activating factor preferentially stimulates the phospholipase A2/cyclooxygenase cascade in the rabbit cornea.
Topics: Animals; Arachidonic Acid; Azepines; Cornea; Dinoprostone; Female; In Vitro Techniques; Male; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rabbits; Thienopyridines; Triazoles | 1995 |
Response of newborn and adult sheep to pyrogens: relation between fever and brain eicosanoid changes.
Topics: Animals; Animals, Newborn; Basal Metabolism; Brain; Cytokines; Dinoprostone; Eicosanoids; Endotoxins; Female; Fever; Injections, Intravenous; Injections, Intraventricular; Male; Platelet Activating Factor; Sheep | 1995 |
Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages.
Topics: Animals; Arachidonic Acid; Bucladesine; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Ibuprofen; Indomethacin; Macrophages, Peritoneal; Male; Naproxen; Platelet Activating Factor; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Terpenes; Thapsigargin | 1995 |
Effects of platelet activating factor on mucociliary clearance of the eustachian tube.
Topics: Animals; Chinchilla; Dinoprostone; Dose-Response Relationship, Drug; Eustachian Tube; Guinea Pigs; Humans; In Vitro Techniques; Infant, Newborn; Male; Mucociliary Clearance; Otitis Media with Effusion; Platelet Activating Factor; Time Factors | 1996 |
Platelet-activating factor production in stimulated macrophages is down-regulated by concurrently produced prostaglandin E2.
Topics: Animals; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Down-Regulation; Indomethacin; Macrophages; Male; Platelet Activating Factor; Protein Kinase C; Rats; Rats, Sprague-Dawley | 1996 |
Platelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion.
Topics: Adult; Animals; Bradykinin; Bradykinin Receptor Antagonists; Coculture Techniques; Colitis, Ulcerative; Colon; Culture Media, Conditioned; Cyclooxygenase Inhibitors; Dinoprostone; Electrophysiology; Female; Histamine; Humans; Intestinal Mucosa; Lipoxygenase Inhibitors; Male; Organ Culture Techniques; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serotonin | 1996 |
Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adolescent; Adult; Aged; Arachidonic Acid; Child; Dinoprostone; Female; Humans; Leukotrienes; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Psoriasis; Thromboxane B2 | 1996 |
Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Azepines; C-Reactive Protein; Dinoprostone; Disease Models, Animal; Indenes; Interleukin-6; Joints; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protease Inhibitors; Rabbits; Random Allocation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Synovial Fluid; Thienopyridines; Triazoles; Tumor Necrosis Factor-alpha; Uric Acid | 1996 |
Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bronchodilator Agents; Chemotaxis, Leukocyte; Complement C5a; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Enzyme Activation; Eosinophils; Humans; Hypersensitivity, Immediate; In Vitro Techniques; Leukotriene C4; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyrrolidinones; Rolipram; Theophylline | 1996 |
Inhibition of zymosan-induced air-pouch inflammation by rat seminal vesicle protein and by its spermidine derivative.
Topics: Animals; Dinoprostone; Inflammation; Male; Mice; Platelet Activating Factor; Prostatic Secretory Proteins; Proteins; Rats; Seminal Plasma Proteins; Spermidine; Zymosan | 1996 |
[Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65].
Topics: Animals; Blood Platelets; Chromatography; Dinoprostone; Electrophoresis, Polyacrylamide Gel; Female; Humans; Male; Mucocutaneous Lymph Node Syndrome; Platelet Activating Factor; Platelet Aggregation; Rabbits; Streptococcus | 1996 |
PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthus Reaction; Cattle; Dinoprostone; Eicosanoids; Indoles; Indomethacin; Injections, Intra-Articular; Leukotriene B4; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Rabbits; Rats; Rats, Wistar; Synovial Fluid; Thromboxane B2; Tumor Necrosis Factor-alpha | 1997 |
Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin.
Topics: Alprostadil; Animals; Bucladesine; Cell Size; CHO Cells; Cholera Toxin; Cricetinae; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Diterpenes; Ginkgolides; Humans; Lactones; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Synthesis Inhibitors; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles | 1997 |
Platelet-activating factor production in the stimulated macrophages is enhanced by the cyclooxygenase inhibitors.
Topics: Animals; Bucladesine; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; In Vitro Techniques; Indomethacin; Macrophages; Macrophages, Peritoneal; Platelet Activating Factor; Rats; Stimulation, Chemical; Thapsigargin | 1996 |
Evidence for activation of cyclooxygenase-1/-2 by endogenous nitric oxide in adjuvant arthritic Lewis rats.
Topics: Animals; Arthritis, Experimental; Dinoprostone; Enzyme Activation; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew | 1996 |
Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
Topics: Alprostadil; Analysis of Variance; Animals; Anti-Ulcer Agents; Carbazoles; Cell Aggregation; Dinoprostone; Dose-Response Relationship, Drug; Eosinophils; Female; Guinea Pigs; Indoles; Misoprostol; Oxytocics; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin D2; Prostaglandins E, Synthetic; Prostanoic Acids; Protein Kinase C; Pyrroles; Receptors, Prostaglandin; Structure-Activity Relationship | 1997 |
Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram.
Topics: Bucladesine; CD11 Antigens; Dinoprostone; Eosinophils; Flow Cytometry; Humans; Isoproterenol; L-Selectin; Neutrophils; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyrrolidinones; Rolipram | 1997 |
Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils.
Topics: CD11 Antigens; CD18 Antigens; Cell Adhesion Molecules; Dexamethasone; Dinoprostone; Down-Regulation; Flow Cytometry; Glucocorticoids; Humans; In Vitro Techniques; Integrins; Intercellular Adhesion Molecule-1; L-Selectin; Leukotriene B4; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Receptors, Glucocorticoid; Up-Regulation | 1997 |
Involvement of phospholipase A2 in gentamicin-induced rat mesangial cell activation.
Topics: Acetates; Animals; Aristolochic Acids; Cell Division; Cell Survival; Cells, Cultured; Dinoprostone; Diterpenes; DNA; Enzyme Inhibitors; Gentamicins; Ginkgolides; Glomerular Mesangium; Kinetics; Lactones; Phenanthrenes; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Quinacrine; Rats; Rats, Wistar; Thymidine; Verapamil | 1997 |
Differential signaling pathways in platelet-activating factor-induced proliferation and interleukin-6 production by rat vascular smooth muscle cells.
Topics: Animals; Calcium Channel Blockers; Cell Division; Cells, Cultured; Cyclic AMP; Cyclooxygenase Inhibitors; Dinoprostone; In Vitro Techniques; Indicators and Reagents; Interleukin-6; Muscle, Smooth, Vascular; Pertussis Toxin; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Protein-Tyrosine Kinases; Rats; Second Messenger Systems; Signal Transduction; Virulence Factors, Bordetella | 1997 |
cAMP mediates homologous downregulation of PAF receptor mRNA expression in mesangial cells.
Topics: Animals; Azepines; Cyclic AMP; Cyclooxygenase Inhibitors; Dinoprostone; Down-Regulation; Female; Glomerular Mesangium; Indomethacin; Kinetics; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Transcription, Genetic; Triazoles; Virulence Factors, Bordetella | 1997 |
Induction and modulation of macrophage Ia antigen expression by platelet-activating factor.
Topics: Animals; Cells, Cultured; Dinoprostone; Female; Histocompatibility Antigens Class II; Interferon-gamma; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Platelet Activating Factor | 1997 |
Influence of interleukin 1alpha on superoxide anion, platelet activating factor release and phospholipase A2 activity of naive and sensitized guinea-pig alveolar macrophages.
Topics: Animals; Cytokines; Dinoprostone; Guinea Pigs; Interleukin-1; Macrophages, Alveolar; N-Formylmethionine Leucyl-Phenylalanine; Oxygen; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Superoxides | 1997 |
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
Topics: Apoptosis; Cytokines; Dinoprostone; Humans; Inflammation; Jurkat Cells; Leukotriene C4; Macrophages; Neutrophils; Phagocytosis; Platelet Activating Factor; Solubility; Thromboxane B2; Transforming Growth Factor beta | 1998 |
Nitric oxide mediates platelet-activating factor stimulatory action on uterine prostaglandin production.
Topics: Animals; Arachidonic Acid; Citrulline; Cyclooxygenase Inhibitors; Dinoprostone; Embryo Implantation; Enzyme Inhibitors; Female; Gestational Age; Indomethacin; Isometric Contraction; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Pregnancy; Prostaglandins; Rats; Rats, Wistar; Uterus | 1998 |
Activation of the prostaglandin EP4-receptor subtype is highly coupled to inhibition of N-formyl-methionyl-leucyl-phenylalanine-stimulated rat neutrophil aggregation.
Topics: Animals; Biphenyl Compounds; Cell Aggregation; Cyclic AMP; Dinoprostone; Epoprostenol; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Rolipram | 1998 |
Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Azepines; Biphenyl Compounds; Chinchilla; Dinoprostone; Ear, Middle; Fatty Acids, Nonesterified; Heptanoic Acids; Hydrolases; Leukotriene Antagonists; Leukotriene C4; Mucous Membrane; Otitis Media; Phospholipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pneumococcal Infections; Propionates; Quinolines; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Thromboxane; Thromboxane B2; Triazoles | 1998 |
Inhibition of tumor necrosis factor-alpha production by SK&F 98625, a CoA-independent transacylase inhibitor, in cultured rat peritoneal macrophages.
Topics: Acyltransferases; Animals; Azepines; Cells, Cultured; Dinoprostone; Enzyme Inhibitors; Furans; Imidazoles; Macrophages, Peritoneal; Male; Organophosphorus Compounds; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Thapsigargin; Triazoles; Tumor Necrosis Factor-alpha | 1998 |
The role of platelet-activating factor in cell infiltration in endotoxin-induced uveitis in guinea pigs.
Topics: Animals; Anterior Chamber; Aqueous Humor; Azepines; Betamethasone; Chemotaxis, Leukocyte; Dinoprostone; Escherichia coli; Flow Cytometry; Guinea Pigs; Indomethacin; Leukocyte Count; Leukocytes; Lipopolysaccharides; Male; Ophthalmic Solutions; Platelet Activating Factor; Platelet Aggregation Inhibitors; Triazoles; Uveitis, Anterior | 1998 |
Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis.
Topics: Arachidonic Acid; Cell Line; Cyclooxygenase 2; Cytokines; Dinoprostone; Epidermis; Humans; Interleukin-6; Interleukin-8; Isoenzymes; KB Cells; Keratinocytes; Membrane Proteins; Models, Biological; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandin-Endoperoxide Synthases; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1998 |
Activation of the small GTPase rap1 in human neutrophils.
Topics: Dinoprostone; Enzyme Activation; Granulocyte-Macrophage Colony-Stimulating Factor; GTP Phosphohydrolases; GTP-Binding Proteins; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; ral Guanine Nucleotide Exchange Factor; rap GTP-Binding Proteins | 1998 |
Effects of lipid mediators on the synthesis of leukaemia inhibitory factor and interleukin 6 by human bone marrow stromal cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Bone Marrow Cells; Cells, Cultured; Culture Media, Serum-Free; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Growth Inhibitors; Humans; Hydroxyeicosatetraenoic Acids; Interleukin-1; Interleukin-6; Leukemia Inhibitory Factor; Leukotriene B4; Lipids; Lymphokines; Platelet Activating Factor; Stromal Cells; Tumor Necrosis Factor-alpha | 1998 |
Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
Topics: Blood Proteins; Calcium; Chemotactic Factors, Eosinophil; Cytokines; Cytosol; Dinoprostone; Dose-Response Relationship, Drug; Eosinophil Granule Proteins; Eosinophils; Histamine; Humans; Inflammation Mediators; Kinetics; Leukotriene B4; Leukotriene C4; Mast Cells; Platelet Activating Factor; Prostaglandin D2; Ribonucleases | 1998 |
[The relationship between the activity of phospholipase A2 and acute hypoxic pulmonary arterial pressure].
Topics: Animals; Dinoprostone; Female; Hypertension, Pulmonary; Hypoxia; Male; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Random Allocation; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 1997 |
Correlation of desensitisation of platelet activating factor (PAF) receptors with intensity of inflammation and intestinal PAF content during experimental ileitis in guinea pig.
Topics: Acetylcholine; Animals; Cell Size; Cholecystokinin; Dinoprostone; Dose-Response Relationship, Drug; Guinea Pigs; Ileitis; Ileum; Male; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Prostaglandin E; Stimulation, Chemical; Time Factors; Trinitrobenzenesulfonic Acid | 1998 |
Responses of guinea-pig lung parenchymal strips to tracheobronchial lavage fluid from horses affected with summer pasture-associated obstructive pulmonary disease.
Topics: Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Dinoprostone; Guinea Pigs; Histamine; Horse Diseases; Horses; In Vitro Techniques; Leukotriene D4; Lung; Lung Diseases, Obstructive; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation Inhibitors; Poaceae; Prostaglandin Antagonists; Quinolines; Reference Values; Seasons; Trachea; Xanthenes; Xanthones | 1998 |
Are lipid mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation?
Topics: 6-Ketoprostaglandin F1 alpha; Anti-Inflammatory Agents; Cardiopulmonary Bypass; Cytokines; Dinoprostone; Extracorporeal Circulation; Humans; Inflammation Mediators; Interleukin-10; Interleukin-4; Interleukin-6; Interleukin-8; Leukotriene B4; Leukotriene C4; Lipid Metabolism; Lipids; Multiple Organ Failure; Platelet Activating Factor; Prospective Studies; Thromboxane B2; Tumor Necrosis Factor-alpha | 1999 |
Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes.
Topics: Corticotropin-Releasing Hormone; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Extraembryonic Membranes; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; In Vitro Techniques; Isoenzymes; Membrane Proteins; Platelet Activating Factor; Pregnancy; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 1999 |
Possible participation of intracellular platelet-activating factor in tumor necrosis factor-alpha production by rat peritoneal macrophages.
Topics: Animals; Azepines; Cells, Cultured; Dinoprostone; Enzyme Inhibitors; Furans; Imidazoles; Indomethacin; Macrophages, Peritoneal; Male; Organophosphorus Compounds; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thapsigargin; Triazoles; Tumor Necrosis Factor-alpha | 1999 |
The production of interleukin-1beta from human fetal membranes is not obligatory for increased prostaglandin output.
Topics: Corticotropin-Releasing Hormone; Culture Techniques; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Extraembryonic Membranes; Gene Expression; Humans; Interleukin-1; Isoenzymes; Membrane Proteins; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 1999 |
Effect of inflammatory mediators on the electrophysiology of the human oviduct.
Topics: Alprostadil; Calcium; Cells, Cultured; Chlorides; Dinoprostone; Electric Conductivity; Electrophysiology; Epithelial Cells; Fallopian Tubes; Female; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Ion Channels; Leukotriene B4; Membrane Potentials; Piperidines; Platelet Activating Factor | 1999 |
15-HETE-substituted diglycerides selectively regulate PKC isotypes in human tracheal epithelial cells.
Topics: Cells, Cultured; Diglycerides; Dinoprostone; Epithelial Cells; Humans; Hydroxyeicosatetraenoic Acids; Intracellular Membranes; Isoenzymes; Platelet Activating Factor; Protein Kinase C; Tissue Distribution; Trachea | 1999 |
Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products.
Topics: Alkanes; Bronchi; Cells, Cultured; Dinoprostone; Enzyme Activation; Epithelial Cells; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Membrane Lipids; Oxidants, Photochemical; Ozone; Peroxides; Phosphatidylcholines; Phospholipases A; Platelet Activating Factor; Type C Phospholipases | 1999 |
Regulation of immunoglobulin G2 production by prostaglandin E(2) and platelet-activating factor.
Topics: Aggressive Periodontitis; Cells, Cultured; Dinoprostone; Humans; Immunoglobulin G; Indomethacin; Macrophages; Monocytes; Phospholipid Ethers; Platelet Activating Factor | 2000 |
Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo.
Topics: Animals; Arginine; Blood Platelets; Dinoprostone; Gastric Mucosa; Helicobacter pylori; Histamine H1 Antagonists; Ketotifen; Leukocytes; Leukotriene B4; Male; Microcirculation; Microscopy, Fluorescence; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyrilamine; Rats; Rats, Wistar; Serum Albumin; Thromboxane A2 | 2000 |
Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Bone Marrow Cells; Cells, Cultured; Cytokines; Dinoprostone; Humans; Hydroxyeicosatetraenoic Acids; Interleukin-1; Leukotriene B4; Lipid Metabolism; Lipoxins; Platelet Activating Factor; Stromal Cells | 2000 |
Thromboxane A(2)-mediated Cl(-) secretion induced by platelet-activating factor in isolated rat colon.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Benzimidazoles; Benzoxepins; Carrier Proteins; Chlorides; Colon; Dinoprostone; Enzyme Inhibitors; Female; Imidazoles; In Vitro Techniques; Indoles; Intestinal Mucosa; Lipoxygenase Inhibitors; Membrane Proteins; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Thromboxane; Secretory Rate; Thromboxane A2; Thromboxane-A Synthase | 2000 |
Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection.
Topics: Animals; Cyclooxygenase 2; Dinoprostone; Isoenzymes; Leishmaniasis; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitric Oxide; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Spleen; Thioglycolates | 2000 |
Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms.
Topics: Amino Acid Sequence; Animals; Arachidonic Acid; Cell Line; Cell Membrane; Dinoprostone; Electrophoresis, Polyacrylamide Gel; Group II Phospholipases A2; Group V Phospholipases A2; Heparan Sulfate Proteoglycans; Heparin; Humans; Hydrogen-Ion Concentration; Hydrolysis; Immunohistochemistry; Leukotriene C4; Mast Cells; Mast-Cell Sarcoma; Mice; Microscopy, Confocal; Models, Biological; Molecular Sequence Data; Mutagenesis, Site-Directed; Phospholipases A; Phosphorylation; Platelet Activating Factor; Protein Binding; Rats; Recombinant Proteins; RNA; Sequence Homology, Amino Acid; Time Factors; Transfection; Tumor Cells, Cultured | 2001 |
Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Bronchi; Cell Line, Transformed; Chemotactic Factors; Dinoprostone; Epithelial Cells; Gene Expression; HeLa Cells; Humans; Hydroxyeicosatetraenoic Acids; Interleukin-6; Leukotriene B4; Platelet Activating Factor; Pneumonia; Respiratory Mucosa; RNA, Messenger | 2001 |
Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
Topics: Arachidonate 5-Lipoxygenase; Cells, Cultured; Culture Media, Conditioned; Cyclooxygenase Inhibitors; Dinoprostone; Down-Regulation; Humans; Immunosuppressive Agents; Indoles; Indomethacin; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-8; Leukocyte Count; Lipopolysaccharides; Lipoxygenase Inhibitors; Neutrophils; Platelet Activating Factor; Pyridinium Compounds; Receptors, Interleukin-1; Receptors, Tumor Necrosis Factor; Sialoglycoproteins; Solubility; Tumor Necrosis Factor-alpha; Up-Regulation | 2001 |
BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents; Carcinogens; Chlorobenzenes; Dinoprostone; Dose-Response Relationship, Drug; Erythema; Female; Guinea Pigs; Humans; Inflammation; Leukotriene B4; Male; Mice; Neutrophils; Phorbol Esters; Phospholipases A; Phospholipases A2; Phospholipids; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Skin; Sulfones | 2001 |
Platelet activating factor increases ciliary activity in the hamster oviduct through epithelial production of prostaglandin E2.
Topics: Animals; Arachidonic Acids; Calcium; Cells, Cultured; Cilia; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Epithelial Cells; Female; Immunohistochemistry; Isoenzymes; Mesocricetus; Nitrobenzenes; Oviducts; Oxytocics; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Signal Transduction; Sulfonamides | 2001 |
Participation of prostaglandin E2 and platelet-activating factor in thapsigargin-induced production of interleukin-6.
Topics: Acetyltransferases; Acyl-Carrier Protein S-Acetyltransferase; Animals; Azepines; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Furans; Imidazoles; Indomethacin; Interleukin-6; Macrophages, Peritoneal; Male; Organophosphorus Compounds; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Messenger; Thapsigargin; Triazoles | 2002 |
Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Carcinoma, Squamous Cell; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Esophageal Neoplasms; Female; Humans; Immunohistochemistry; Interleukin-6; Isoenzymes; Male; Membrane Proteins; Middle Aged; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandin-Endoperoxide Synthases; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 2002 |
Platelet-activating factor increases prostaglandin E(2) release from astrocyte-enriched cortical cell cultures.
Topics: Animals; Arachidonic Acid; Astrocytes; Binding Sites; Cells, Cultured; Cerebral Cortex; Dinoprostone; Diterpenes; Drug Synergism; Female; Ginkgolides; Lactones; Osmolar Concentration; Phospholipid Ethers; Platelet Activating Factor; Pyridinium Compounds; Rats; Solvents | 2002 |
Platelet-activating factor-induced pulmonary edema is partly mediated by prostaglandin E(2), E-prostanoid 3-receptors, and potassium channels.
Topics: Animals; Culture Techniques; Dinoprostone; Disease Models, Animal; Female; Mice; Platelet Activating Factor; Potassium Channels; Probability; Pulmonary Edema; Rats; Rats, Wistar; Receptors, Prostaglandin E; Reference Values; Sensitivity and Specificity | 2002 |
Cyclooxygenase-2 mediates platelet-activating factor-induced prostaglandin E2 release from rat primary astrocytes.
Topics: Animals; Astrocytes; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Isoenzymes; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats | 2003 |
Kupffer cells are a major source of increased platelet activating factor in the CCl4-induced cirrhotic rat liver.
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Dinoprostone; Endothelin-1; Gene Expression; Kupffer Cells; Liver Cirrhosis; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptor, Endothelin B; Receptors, G-Protein-Coupled | 2003 |
PAF-like lipids- and PAF-induced gallbladder muscle contraction is mediated by different pathways in guinea pigs.
Topics: Animals; Dinoprostone; Gallbladder; Guinea Pigs; Hydrogen Peroxide; Lipid Metabolism; Male; Muscle Contraction; Muscle, Smooth; Oxidants; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled | 2003 |
IL-4 primes human endothelial cells for secondary responses to histamine.
Topics: Calcium; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Histamine; Humans; Interleukin-1; Interleukin-4; Oncostatin M; Oxytocics; Peptides; Platelet Activating Factor; Receptors, Histamine; Signal Transduction; Tumor Necrosis Factor-alpha; Umbilical Veins; Up-Regulation | 2003 |
Sulfur-related air pollutants induce the generation of platelet-activating factor, 5-lipoxygenase- and cyclooxygenase-products in canine alveolar macrophages via activation of phospholipases A2.
Topics: Air Pollutants; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Autoradiography; Carbon Radioisotopes; Cells, Cultured; Chromatography, Thin Layer; Dinoprostone; Dogs; Enzyme Activation; Fatty Acids, Unsaturated; Hydrogen-Ion Concentration; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Macrophages, Alveolar; Phospholipases A; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Sulfates; Sulfites; Sulfur; Thromboxane B2 | 2003 |
Developmental regulation of prostaglandin E2 synthase in porcine ductus arteriosus.
Topics: Animals; Animals, Newborn; Cyclooxygenase 2; Cytosol; Dinoprostone; Ductus Arteriosus; In Vitro Techniques; Intramolecular Oxidoreductases; Isoenzymes; Phospholipases A; Platelet Activating Factor; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Swine | 2004 |
Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression.
Topics: Administration, Cutaneous; Animals; Ascorbic Acid; Cell Line; Dinoprostone; Female; Hydrocarbons; Hypersensitivity, Delayed; Keratinocytes; Mice; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Vitamin E | 2004 |
The role of platelet activating factor in prion and amyloid-beta neurotoxicity.
Topics: Amyloid beta-Peptides; Brain Neoplasms; Caspase 3; Caspases; Cell Death; Dinoprostone; Humans; Nervous System Diseases; Neuroblastoma; Peptide Fragments; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Prions; Tumor Cells, Cultured | 2004 |
Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication.
Topics: Cell Line; Cell Line, Tumor; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Glucocorticoids; Humans; Phospholipases A; Phospholipases A2; Phospholipids; Platelet Activating Factor; Prions; PrPSc Proteins; Signal Transduction; Time Factors | 2004 |
PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells.
Topics: Animals; Antigens; Antigens, Bacterial; Arthritis, Rheumatoid; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Enzyme Inhibitors; Isoenzymes; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred C3H; Mitogens; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peritoneum; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Proteins; Signal Transduction; Superantigens; Up-Regulation | 2004 |
Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats.
Topics: Alendronate; Alveolar Bone Loss; Animals; Anti-Bacterial Agents; Dinoprost; Dinoprostone; Doxycycline; Drug Therapy, Combination; Endotoxins; Gingiva; Leukotriene B4; Male; Periodontitis; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 2004 |
Therapeutic versus prophylactic plus therapeutic administration of omega-3 fatty acid on endotoxin-induced periodontitis in rats.
Topics: Alveolar Bone Loss; Analysis of Variance; Animals; Dinoprost; Dinoprostone; Endotoxins; Fatty Acids, Omega-3; Gingiva; Immunoenzyme Techniques; Inflammation Mediators; Leukotriene B4; Male; Periodontitis; Platelet Activating Factor; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric | 2004 |
Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Endotoxins; Fatty Acids, Omega-3; Leukotriene B4; Male; Periodontitis; Platelet Activating Factor; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2005 |
Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis.
Topics: Acetylcholine; Animals; Cats; Dinoprostone; Esophagitis; Esophagus; Inflammation; Interleukin-1; Interleukin-6; Male; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Reactive Oxygen Species | 2005 |
Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
Topics: Animals; Arachidonic Acid; Dinoprostone; Dose-Response Relationship, Drug; Exocytosis; Fibrinolytic Agents; Korea; Male; Mice; Mice, Inbred ICR; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Thromboxane A2 | 2005 |
Decreased cation channel activity and blunted channel-dependent eryptosis in neonatal erythrocytes.
Topics: Adult; Aging; Aniline Compounds; Annexin A5; Apoptosis; Calcium; Cations; Cell Separation; Chlorides; Cytosol; Dinoprostone; Erythrocytes; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Infant, Newborn; Ion Channels; Osmotic Pressure; Oxidative Stress; Patch-Clamp Techniques; Phosphatidylserines; Platelet Activating Factor; tert-Butylhydroperoxide; Xanthenes | 2006 |
Interaction of macrophages with apoptotic cells enhances HIV Type 1 replication through PGE2, PAF, and vitronectin receptor.
Topics: Apoptosis; Celecoxib; Cyclooxygenase Inhibitors; Dinoprostone; Diterpenes; Ginkgolides; HIV-1; Humans; In Vitro Techniques; Integrin alphaVbeta3; Lactones; Macrophages; Phagocytosis; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyrazoles; Receptors, G-Protein-Coupled; Sulfonamides; Virus Replication | 2006 |
Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bradykinin; Carrageenan; Dinoprostone; Dose-Response Relationship, Drug; Edema; Foot; Hindlimb; Histamine; Indomethacin; Injections, Intraperitoneal; Leukocytes; Lipoxins; Male; Mice; Neutrophil Infiltration; Oligopeptides; Platelet Activating Factor; Pleurisy; Receptors, Lipoxin | 2006 |
Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils.
Topics: Arachidonic Acids; Dinoprostone; Dose-Response Relationship, Drug; Eicosanoids; Enzyme Inhibitors; Group IV Phospholipases A2; Humans; In Vitro Techniques; Leukotrienes; Neutrophils; Organophosphonates; Phospholipase D; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pyrrolidines | 2006 |
Activation of platelet-activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production.
Topics: Calcium Signaling; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Gene Expression Regulation; Humans; Interleukin-8; Membrane Proteins; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Sebaceous Glands | 2006 |
The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis.
Topics: Dinoprostone; Humans; Imidazoles; Inflammation Mediators; Leukotriene B4; Neutrophils; Platelet Activating Factor; RNA Viruses; Signal Transduction; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2007 |
Dietary ganglioside inhibits acute inflammatory signals in intestinal mucosa and blood induced by systemic inflammation of Escherichia coli lipopolysaccharide.
Topics: Animals; Cholesterol; Dietary Fats; Dinoprostone; Gangliosides; Inflammation; Interleukin-1beta; Intestinal Mucosa; Leukotriene B4; Lipopolysaccharides; Male; Membrane Microdomains; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2007 |
Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells.
Topics: Anti-Inflammatory Agents; Budesonide; Cell Survival; Cells, Cultured; Cyclic N-Oxides; Cyclooxygenase 2; Dihydropyridines; Dinoprostone; Drug Synergism; Encephalitis; Gene Expression; Humans; Neurons; Oxidative Stress; Platelet Activating Factor; Signal Transduction; Stress, Physiological; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation | 2007 |
A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine.
Topics: Animals; Cell Survival; Cells, Cultured; Cholinesterase Inhibitors; Chromatin; Cyclooxygenase 2 Inhibitors; Dinoprostone; Furans; Glutathione; Macrophages; Mice; Mitochondria; Nitric Oxide; Oxidative Stress; Platelet Activating Factor; Tacrine; Tumor Necrosis Factor-alpha | 2007 |
Prostaglandin I2 plays a key role in zymosan-induced mouse pleurisy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Complement C3; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Elapid Venoms; Epoprostenol; Indomethacin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pleurisy; Pyrazoles; Receptors, G-Protein-Coupled; Receptors, Prostaglandin; Zymosan | 2008 |
Effects of dietary supplementation with fish oil on in vivo production of inflammatory mediators in clinically normal dogs.
Topics: Animals; Area Under Curve; Cytokines; Dietary Supplements; Dinoprostone; Docosahexaenoic Acids; Dogs; Eicosapentaenoic Acid; Female; Interleukin-1; Interleukin-6; Male; Platelet Activating Factor; Random Allocation; Tumor Necrosis Factor-alpha; Vitamin E | 2008 |
Tryptase activates calcium-independent phospholipase A2 and releases PGE2 in airway epithelial cells.
Topics: Cell Adhesion; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Humans; Neutrophils; Phospholipases A2, Calcium-Independent; Phospholipid Ethers; Platelet Activating Factor; Respiratory System; Subcellular Fractions; Tryptases | 2008 |
Platelet-activating factor-stimulated production of reactive oxygen species in ovarian granulosa cells from periovulatory follicles.
Topics: Animals; Calcium Signaling; Cattle; Dinoprostone; Female; Fluorescent Dyes; Gene Expression Regulation; Granulosa Cells; Intracellular Space; Ovulation; Oxidation-Reduction; Platelet Activating Factor; Reactive Oxygen Species; RNA, Messenger | 2009 |
Effect of baicalin on inflammatory mediator levels and microcirculation disturbance in rats with severe acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascites; Dinoprostone; Flavonoids; Inflammation Mediators; Interleukin-1beta; Male; Microcirculation; Pancreas; Pancreatitis; Phospholipases A2; Platelet Activating Factor; Random Allocation; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 2009 |
Platelet-activating factor-induced intracellular signaling and release of cytokines and prostaglandin E2 in immortalized human corneal epithelial cells.
Topics: Biological Transport; Calcium; Cell Line, Transformed; Cell Proliferation; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Epithelium, Corneal; Fluorometry; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inflammation Mediators; Intracellular Membranes; Matrix Metalloproteinase 1; Osmolar Concentration; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction; Thymidine | 2010 |
The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Blood Platelets; Calcium Signaling; Cell Adhesion Molecules; Cyclic AMP; Dinoprostone; Humans; Microfilament Proteins; Naphthalenes; Oligopeptides; P-Selectin; Phenylbutyrates; Phosphoproteins; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype | 2010 |
Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy.
Topics: Animals; Cell Death; Cytokines; Dihydropyridines; Dinoprostone; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Kindling, Neurologic; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyramidal Cells; Rats; Rats, Wistar; Receptors, G-Protein-Coupled | 2011 |
Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage.
Topics: Aged; Aged, 80 and over; Arachidonic Acid; Cartilage, Articular; Cells, Cultured; Chondrocytes; Dinoprostone; Female; Humans; Inflammation; Interleukin-1beta; Isoenzymes; Male; Middle Aged; Oleic Acid; Osteoarthritis, Hip; Osteoarthritis, Knee; Phospholipases A2; Platelet Activating Factor; RNA, Messenger; Tumor Necrosis Factor-alpha | 2011 |
Regulation of coronary venular barrier function by blood borne inflammatory mediators and pharmacological tools: insights from novel microvascular wall models.
Topics: Actins; Arterioles; Blood Platelets; Blood Proteins; Capillaries; Capillary Permeability; Cells, Cultured; Coronary Circulation; Dinoprostone; Drug Synergism; Endothelial Cells; Erythrocytes; Hemostatics; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Leukotriene B4; Myocarditis; Pericytes; Platelet Activating Factor; Thrombin; Venules | 2012 |
Effect of epinephrine on platelet-activating factor-stimulated human vascular smooth muscle cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Anaphylaxis; Aorta; Cells, Cultured; Dinoprostone; Epinephrine; Humans; Myocytes, Smooth Muscle; Platelet Activating Factor | 2012 |
Inhibitory effects of acetylmelodorinol, chrysin and polycarpol from Mitrella kentii on prostaglandin E₂ and Thromboxane B₂ production and platelet activating factor receptor binding.
Topics: Alkenes; Animals; Annonaceae; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Flavonoids; Humans; Inhibitory Concentration 50; Plant Extracts; Plant Leaves; Platelet Activating Factor; Platelet Membrane Glycoproteins; Polycyclic Aromatic Hydrocarbons; Rabbits; Radioimmunoassay; Receptors, G-Protein-Coupled; Thromboxane B2 | 2012 |
Platelet-Activating Factor-Induced Reduction in Contact Hypersensitivity Responses Is Mediated by Mast Cells via Cyclooxygenase-2-Dependent Mechanisms.
Topics: Animals; Carboxy-Lyases; Cell Movement; Cyclooxygenase 2; Dermatitis, Contact; Dinoprostone; Female; Immunosuppression Therapy; Lymph Nodes; Male; Mast Cells; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Receptors, G-Protein-Coupled | 2018 |
Exosomal PGE2 from M2 macrophages inhibits neutrophil recruitment and NET formation through lipid mediator class switching in sepsis.
Topics: Animals; Dinoprostone; Extracellular Traps; Immunoglobulin Class Switching; Lung Injury; Macrophages; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Neutrophils; Platelet Activating Factor; Sepsis | 2023 |